<SEC-DOCUMENT>0001828316-24-000035.txt : 20241024
<SEC-HEADER>0001828316-24-000035.hdr.sgml : 20241024
<ACCEPTANCE-DATETIME>20241024060228
ACCESSION NUMBER:		0001828316-24-000035
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20241024
FILED AS OF DATE:		20241024
DATE AS OF CHANGE:		20241024

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Pharming Group N.V.
		CENTRAL INDEX KEY:			0001828316
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			P7
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39822
		FILM NUMBER:		241390462

	BUSINESS ADDRESS:	
		STREET 1:		DARWINWEG 24
		CITY:			LEIDEN
		STATE:			P7
		ZIP:			2333 CR
		BUSINESS PHONE:		31 (0)71 5247 400

	MAIL ADDRESS:	
		STREET 1:		DARWINWEG 24
		CITY:			LEIDEN
		STATE:			P7
		ZIP:			2333 CR

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Pharming Group Group N.V.
		DATE OF NAME CHANGE:	20201014
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>a2024q3pressrelease.htm
<DESCRIPTION>6-K
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="ia539f3d4cede4c79844ea01b8e3be3da_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3pt;text-align:center"><font><br></font></div><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:115%">UNITED STATES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:115%">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Washington, D.C. 20549</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:115%">FORM 6-K</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">REPORT OF FOREIGN PRIVATE ISSUER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">PURSUANT TO RULE 13a-16 OR 15d-16</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">UNDER THE SECURITIES EXCHANGE ACT OF 1934</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">For the Month of October 2024</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Commission File Number&#58; 001-39822</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:115%">Pharming Group N.V.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(Exact Name of Registrant as Specified in Its Charter)</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Darwinweg 24</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">2333 CR Leiden</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">The Netherlands</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(Address of principal executive offices)</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Form 20-F </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9746;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">           Form 40-F </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9744;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1)&#58;  </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9744;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7)&#58;  </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9744;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Furnished as Exhibit 99.1 to this Report on Form 6-K is a press release of Pharming Group N.V., dated October 24, 2024.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#59595b;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">EXHIBIT INDEX</font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"><tr><td style="width:1.0%"></td><td style="width:14.071%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.071%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:68.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Exhibit No.</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Description</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">99.1</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pharming Group reports third quarter 2024 financial results and provides business update</font></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">SIGNATURE</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.403%"><tr><td style="width:1.0%"></td><td style="width:27.340%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.156%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pharming Group N.V.</font></div></td></tr><tr style="height:33pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">By&#58;</font></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#47;s&#47; Sijmen de Vries</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Name&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Sijmen de Vries</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Title&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">CEO</font></div></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Date&#58; October 24, 2024</font></div><div id="ia539f3d4cede4c79844ea01b8e3be3da_4"></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:center"><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#59595b;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><img alt="logo_pharmingxoriginal.jpg" src="logo_pharmingxoriginal.jpg" style="height:71px;margin-bottom:5pt;vertical-align:text-bottom;width:210px"></div></div><div style="text-align:center"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:18pt;font-weight:700;line-height:120%">Pharming Group reports third quarter 2024 financial results and provides business update</font></div><div style="text-align:center"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:12.53pt">Third quarter 2024 total revenues </font><font style="background-color:#ffffff;color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">increased</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> by 12% to US$74.8 million, compared to the third quarter 2023,</font><font style="background-color:#ffffff;color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> driven by continued strong RUCONEST&#174; and Joenja&#174; revenue growth</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:12.53pt">RUCONEST&#174; third quarter revenu</font><font style="background-color:#ffffff;color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">e increased by </font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6% to US$63.6 million, compared to the third quarter 2023</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:12.53pt">Joenja&#174; (leniolisib) third quarter reven</font><font style="background-color:#ffffff;color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ue increased b</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">y 72% to US$11.2 million, compared to the third quarter 2023 </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:12.53pt">First nine months total revenu</font><font style="background-color:#ffffff;color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">es increased </font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">by 25% to US$204.5 million, compared to the first nine months 2023</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:12.53pt">On track for 2</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">024 total revenue guidance of US$280 million - US$295 million (14 - 20% growth)</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:12.53pt">Third quarter operating profit increased to US$4.1 million from US$1.9 million in the third quarter 2023</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:12.53pt">Overall cash and marketable securities increased to US$173.3 million at the end of the third quarter 2024 from US$161.8 million at the end of the second quarter 2024</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:12.53pt">Sijmen de Vries, our Executive Director&#47;Chief Executive Officer, has informed the Board of Directors that he will not be available for reappointment at the next Annual General Meeting of Shareholders in May 2025</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:12.53pt">Pharming to host a conference call today at 13&#58;30 CEST (7&#58;30 am EDT)</font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Leiden, the Netherlands, October 24, 2024&#58; </font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pharming Group N.V. (&#8220;Pharming&#8221; or &#8220;the Company&#8221;) (Euronext Amsterdam&#58; PHARM&#47;NASDAQ&#58; PHAR) presents its preliminary, unaudited financial report for the three months ended September&#160;30, 2024.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Chief Executive Officer, Sijmen de Vries, commented&#58;</font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Pharming has delivered an excellent third quarter, increasing quarterly revenues by 12% to a record-high US$74.8 million and also achieving record revenues of US$204.5 million for the first nine months of the year. The combination of strong revenue performance, combined with reduced operating expenses compared to the previous quarter, enabled us to realize a positive operating profit in the third quarter. We are firmly on track to meet our 2024 total revenue guidance of US$280 million - US$295 million (14 - 20% growth). </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">The third quarter demonstrated Pharming&#8217;s ability to deliver continued growth for RUCONEST&#174; in the competitive U.S. HAE market, with strength in underlying demand including new patient enrollments. Third quarter revenue for this product increased by 6% compared to the same quarter in 2023.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">For Joenja&#174;, we continue to both increase the number of patients on therapy quarter-on-quarter and to maintain high adherence rates for these patients. We received U.K. approval for Joenja&#174; (leniolisib) in September, demonstrating our active efforts with regulatory authorities to make this medicine available to as many patients as possible, and now look forward to the results of the reimbursement evaluation over the coming quarters and to a subsequent commercial launch.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">In October 2024, we announced the start of a Phase II, proof of concept, clinical trial evaluating leniolisib in primary immunodeficiencies (PIDs) with immune dysregulation linked to PI3K&#7839; signaling. This is an important step for Pharming as this trial will include patients with various PIDs with significant unmet medical need and much higher overall prevalence than APDS, including ALPS-FAS, CTLA4 </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#59595b;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><img alt="logo_pharmingxoriginal.jpg" src="logo_pharmingxoriginal.jpg" style="height:71px;margin-bottom:5pt;vertical-align:text-bottom;width:210px"></div></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">haploinsufficiency, NFKB1 haploinsufficiency and PTEN deficiency. With prevalence of approximately seven patients per million, these PIDs represent a potential five-fold increase in the commercial opportunity for leniolisib, thereby ensuring Pharming is delivering on its mission to serve the unserved rare disease patient.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">I have informed the Board of Directors that I will not be available, after a 16 year tenure at the helm of Pharming, for reappointment as Executive Director&#47;Chief Executive Officer. Our company is in great shape today. So this is the right moment for me to make way for a successor to lead Pharming into the next chapter of its strategy for growth, building on the achievements of the past years. I am proud of all these achievements and grateful for the trust put in me by our patients, employees and investors over the years. I will continue to dedicate myself fully to Pharming until my successor has been appointed and will do everything in my power to ensure a smooth hand-over.&#8221; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Chairman of the Board of Directors, Dr. Richard Peters, commented&#58;</font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;On behalf of the entire Board of Directors, I would like to thank Sijmen de Vries for his high commitment to Pharming over the past 16 years and for the way he has created the company that it is today, serving patients and paving the way for the delivery on the company&#8217;s strategy for growth.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">The Board of Directors has engaged a leading global executive search firm for the search of a successor. Further announcements will be made when appropriate.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">We will of course take time to celebrate Sijmen&#8217;s tenure as our CEO in the coming months.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Third quarter highlights</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Commercialized products</font></div><div><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:120%">RUCONEST&#174; marketed for the treatment of acute HAE attacks</font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">RUCONES</font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">T&#174; continued to perform well in the third quarter of 2024, with revenues of US$63.6 million, a 6% increase comp</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ared to the third quarter of 2023. Revenue for the first nine months of 2024 was US$172.6 million, a 12% increase compared to the same period in 2023.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The U.S. market contributed 97% of third quarter revenues, while the EU and Rest of World contributed 3%.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the U.S. market, we saw continued strength in the third quarter in underlying in-market demand, including approximately 100 new patient enrollments. We achieved strong overall performance in the third quarter in other leading key revenue indicators including the number of prescribers, the total number of patients on therapy, and vials shipped to patients. Increasing enrollments helped to drive a sharp increase in unique patient shipments in the third quarter. </font></div><div><font><br></font></div><div><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Joenja&#174; (leniolisib) marketed for the treatment of APDS</font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Joenja&#174; revenues increased to </font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">US$11.2 million</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> in the third quarter of 2024, a 72% increase compared to the third quarter of </font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2023</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. This increase was mostly driven by higher volume from the 50% increase in patients on paid therapy in the U.S. compared to the third quarter of 2023, and revenues from EU and Rest of World which are from product provided on a named patient basis. Revenue for the first nine months of 2024 was US$31.9 million, compared to </font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">US$10.3 million</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> for the same period in 2023.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#59595b;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><img alt="logo_pharmingxoriginal.jpg" src="logo_pharmingxoriginal.jpg" style="height:71px;margin-bottom:5pt;vertical-align:text-bottom;width:210px"></div></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of </font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">September 30, 2024,</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> we have 93 patients on paid therapy in the U.S. and an additional five patients enrolled and pending authorization, representing an increase of both active and pending patients during the third quarter and continued progress enrolling and moving eligible patients to paid therapy.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Joenja&#174; (leniolisib) development updates</font></div><div><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Leniolisib for APDS</font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pharming made continued progress in the third quarter of 2024 on leniolisib regulatory filings for APDS patients 12 years of age and older in key global markets. Pharming is on track to complete the manufacturing activities requested by the European Medicines Agency&#8217;s (EMA) Committee for Human Medicinal Products (CHMP) and submit a response prior to the January 2026 deadline. In addition, Pharming progressed ongoing clinical trials to support regulatory filings for approval in Japan and pediatric label expansion beginning in 2025. Data readout from the clinical trial for children ages 4 to 11 years old is expected in the fourth quarter of 2024.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In total, there are currently 164 patients in a leniolisib Expanded Access Program (compassionate use), an ongoing clinical study, or a named patient program.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">United Kingdom</font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On September 25, 2024, the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) granted marketing authorization for Joenja&#174; (leniolisib) for the treatment of APDS in adult and pediatric patients 12 years of age and older. Joenja&#174; was the first new medicine approved by the MHRA via the International Recognition Procedure (IRP) using the U.S. FDA as reference regulator. Leniolisib is currently under evaluation by the National Institute for Health and Care Excellence (NICE) regarding reimbursement within the National Health Service (NHS) in England.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Leniolisib for additional indications (PI3K&#948; platform) - Primary immunodeficiencies (PIDs) beyond APDS</font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On October 10, 2024, Pharming announced the start of a Phase II, proof of concept, clinical trial evaluating leniolisib in PIDs with immune dysregulation linked to PI3K&#7839; signaling in lymphocytes, with similar clinical phenotypes and unmet medical needs to APDS. The first patient is expected to be enrolled in the study in the coming weeks. The clinical trial will include PID patients with ALPS-FAS, CTLA4 haploinsufficiency, NFKB1 haploinsufficiency and PTEN deficiency, among others. Epidemiology suggests a prevalence of approximately seven patients per million in this targeted PID population, compared to one to two patients per million for APDS. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Phase II clinical trial is a single arm, open-label, dose range-finding study to be conducted in approximately 12 patients. The objectives for the trial will be to assess safety and tolerability, pharmacokinetics, pharmacodynamics, and explore clinical efficacy of leniolisib in the targeted PID population. The trial has been designed to inform a subsequent Phase III program.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pharming has also prioritized development of leniolisib for an additional PID indication. Pharming will provide further updates and details on our plans, including the proposed clinical development plan, later this year.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#59595b;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><img alt="logo_pharmingxoriginal.jpg" src="logo_pharmingxoriginal.jpg" style="height:71px;margin-bottom:5pt;vertical-align:text-bottom;width:210px"></div></div><div><font style="color:#116a9e;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Organizational update</font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Sijmen de Vries, our Executive Director&#47;Chief Executive Officer, has informed the Board of Directors that he will not be available for reappointment at the Company&#8217;s next Annual General Meeting of Shareholders (AGM) in May 2025. The mandate of Sijmen de Vries is scheduled to expire at the closing of the AGM to be held in May 2025. Further announcements on the search of a successor will be made when appropriate.</font></div><div><font><br></font></div><div><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Financial Summary </font></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"></td><td style="width:36.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.523%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#00629a;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statement of Income</font></td><td colspan="3" style="background-color:#55b0e4;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3Q 2024</font></td><td colspan="3" style="background-color:#00629a;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3Q 2023</font></td><td colspan="3" style="background-color:#55b0e4;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9M 2024</font></td><td colspan="3" style="background-color:#00629a;border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9M 2023</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Amounts in US$m except per share data</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f1f1f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenues</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">74.8</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">66.7</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">204.5</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">164.1</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.8)</font></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.3)</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.2)</font></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.1)</font></td></tr><tr><td colspan="3" style="background-color:#f1f1f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross profit</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68.0</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">58.4</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">181.3</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">146.0</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8</font></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1</font></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.8</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.7)</font></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.8)</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60.8)</font></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57.3)</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.3)</font></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.9)</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.0)</font></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.9)</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing and sales</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.7)</font></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.1)</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91.9)</font></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86.1)</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Operating Costs</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(64.7)</font></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(56.8)</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(198.7)</font></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(175.3)</font></td></tr><tr><td colspan="3" style="background-color:#f1f1f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating profit (loss)</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.1</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.9</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(15.3)</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6.5)</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance income (expense) and share of net profits in associates</font></div></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</font></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1</font></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</font></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Profit (loss) before tax</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.5</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.3</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(15.2)</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(10.0)</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax credit (expense)</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</font></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</font></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6</font></td></tr><tr><td colspan="3" style="background-color:#f1f1f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Profit (loss) for the period</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.0)</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.5</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(14.7)</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7.4)</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Share Information</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share (US$)</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.002)</font></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.005</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.022)</font></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.011)</font></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #9d9d9c;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share (US$)</font></td><td colspan="3" style="background-color:#ddeffa;border-bottom:0.25pt solid #9d9d9c;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.002)</font></td><td colspan="3" style="border-bottom:0.25pt solid #9d9d9c;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.005</font></td><td colspan="3" style="background-color:#ddeffa;border-bottom:0.25pt solid #9d9d9c;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.022)</font></td><td colspan="3" style="border-bottom:0.25pt solid #9d9d9c;border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.011)</font></td></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"></td><td style="width:36.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.523%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#00629a;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment information - Revenues</font></div></td><td colspan="3" style="background-color:#55b0e4;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3Q 2024</font></td><td colspan="3" style="background-color:#00629a;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3Q 2023</font></td><td colspan="3" style="background-color:#55b0e4;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9M 2024</font></td><td colspan="3" style="background-color:#00629a;border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9M 2023</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt;padding-right:13.5pt;text-align:justify"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Amounts in US$m</font></div></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue - RUCONEST&#174; (US)</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.0</font></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.4</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168.4</font></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.3</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue - RUCONEST&#174; (EU and RoW)</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6</font></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</font></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</font></td></tr><tr><td colspan="3" style="background-color:#f1f1f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenues - RUCONEST&#174;</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">63.6</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">60.2</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">172.6</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">153.8</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue - Joenja&#174; (US)</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0</font></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.7</font></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue - Joenja&#174; (EU and RoW)</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2</font></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</font></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#f1f1f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenues - Joenja&#174;</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.2</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.5</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31.9</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.3</font></td></tr><tr style="height:5pt"><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f1f1f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenues - US</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">72.0</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">64.9</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">197.1</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">159.6</font></td></tr><tr><td colspan="3" style="background-color:#f1f1f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenues - EU and RoW</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.8</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.8</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.4</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.5</font></td></tr><tr style="height:5pt"><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f1f1f2;border-bottom:0.25pt solid #9d9d9c;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenues</font></td><td colspan="3" style="background-color:#ddeffa;border-bottom:0.25pt solid #9d9d9c;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">74.8</font></td><td colspan="3" style="background-color:#f2f2f2;border-bottom:0.25pt solid #9d9d9c;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">66.7</font></td><td colspan="3" style="background-color:#ddeffa;border-bottom:0.25pt solid #9d9d9c;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">204.5</font></td><td colspan="3" style="background-color:#f2f2f2;border-bottom:0.25pt solid #9d9d9c;border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">164.1</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#59595b;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><img alt="logo_pharmingxoriginal.jpg" src="logo_pharmingxoriginal.jpg" style="height:71px;margin-bottom:5pt;vertical-align:text-bottom;width:210px"></div></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"><tr><td style="width:1.0%"></td><td style="width:60.190%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.256%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#00629a;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Balance Sheet</font></td><td colspan="3" style="background-color:#55b0e4;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2024</font></td><td colspan="3" style="background-color:#00629a;border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Amounts in US$m</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#595959;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents, restricted cash and marketable securities</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">173.3</font></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">215.0</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#595959;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">282.2</font></td><td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">316.3</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#595959;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">425.5</font></td><td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">462.9</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#595959;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</font></td><td colspan="3" style="background-color:#ddeffa;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">79.8</font></td><td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">78.0</font></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #9d9d9c;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#595959;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity</font></td><td colspan="3" style="background-color:#ddeffa;border-bottom:0.25pt solid #9d9d9c;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">225.8</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:0.25pt solid #9d9d9c;border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">218.8</font></td></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt"><font><br></font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:115%">Financial highlights</font></div><div><font style="background-color:#ffffff;color:#00629a;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Third quarter 2024</font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For the third quarter of 2024, total revenues increased by US$8.2 million, or 12%, to US$74.8 million, compared to US$66.7 million in the third quarter of </font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2023</font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. RUCONEST&#174; revenues amounted to US$63.6 million, a 6% increase compared to the third quarter of </font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2023</font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The volume increase in the U.S., and a U.S. price increase in line with CPI, were the primary factors behind this increase in RUCONEST&#174; revenues. Joenja&#174; revenues amounted to US$11.2 million in the third quarter of 2024, a 73% increase compared to the third quarter of </font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2023</font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. This increase was primarily driven by an increase in volume.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Gross profit increased by US$9.7 million or 17% to US$68.0 million (3Q 2023&#58; US$58.4 million), mainly due to the increase in revenues.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The operating profit amounted to </font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">US$4.1 million</font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> compared to an operating profit of US$1.9 million</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in the third quarter of 2023. This increase was primarily due to the increase in gross profit mentioned above, offset by the increase in</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">operating expenses from </font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">US$56.8 million</font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> in the third quarter of 2023 to </font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">US$64.7 million</font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The increase in operating expenses compared to the same quarter in 2023 was caused by a combination of continuing investments in Joenja&#174; in the U.S., launch preparation for leniolisib outside of the U.S., increasing R&#38;D investments to expand the leniolisib franchise and increased payroll expenses due to business growth. Third quarter 2024 operating expenses decreased </font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8% from</font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">US$70.1 million in</font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the second quarter of 2024</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The net finance result amounted to a loss of US$2.2 million compared to a gain of US$1.9 million in the third quarter of 2023. This was primarily driven by unfavora</font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ble EUR&#47;USD exchange rate developments, resulting in a foreign currency loss of US$1.5 million compared to a gain of US$1.7 million in the third quarter of 2023. Additionally, interest expense increased by US$1.0 million in the third quarter of 2024 compared to the previous year, following the convertible bond issuance in the second quarter of 2024.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company had </font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a net loss of US$1.0 million</font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, compared to a net profit of </font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">US$3.5 million</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in the third quarter of 2023. This change was mainly due to higher finance expense resulting from unfavorable EUR&#47;USD exchange rate developments and higher income tax expenses, despite higher operating profit. While the exchange rate fluctuations resulted in a foreign currency loss in the income statement, currency translation differences in other comprehensive income led to a positive result of </font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">US$2.9 million</font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, compared to a negative result of </font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">US$5.2 million</font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> in the third quarter of 2023. This outcome was driven by the Company&#8217;s predominantly euro-denominated assets, including the vast majority of the cash and marketable securities position.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Cash and cash equivalents, including restricted cash and marketable securities, increased from </font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">US$161.8 million</font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> at the end of second quarter of 2024 to </font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">US$173.3 million</font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> at the end of the third quarter of 2024. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#59595b;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><img alt="logo_pharmingxoriginal.jpg" src="logo_pharmingxoriginal.jpg" style="height:71px;margin-bottom:5pt;vertical-align:text-bottom;width:210px"></div></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This increase was primarily driven by positive cash flows from operations of </font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">US$9.7 million (3Q 2023&#58; US$3.5 million</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">)</font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, which includes a deduction of </font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">US$9.1 million</font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> in paid taxes (3Q </font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2023</font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; </font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">US$0.0 million</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">)</font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Nine months 2024</font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Total revenues increased 25% during the first nine months of 2024 to US$204.5 million, versus US$164.1 million during the first nine</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> months of 2023. Total RUCONEST&#174; revenues were 12% higher at US$172.6 million, compared to revenues of US$153.8 million for the first nine months of 2023. Joenja&#174; revenues amounted to US$31.9 million in the first nine months of 2024, a 210% increase compared to the first nine months of </font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2023 (first sales commenced at the start of the second quarter of </font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2023</font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">)</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. This increase was primarily driven by an increase in volume.</font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Gross profit increased by US$35.3 million or 24% to US$181.3 million (9M </font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2023</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; US$146.0 million), mainly due to the increase in revenues.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Other income decreased to US$2.0 million compared to US$22.8 million in the first nine months of </font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2023</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Other income in the first nine months of </font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2023</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> was supported by the sale of the Rare Pediatric Disease Priority Review Voucher (PRV) to Novartis for a pre-agreed, one-time payment of US$21.1 million</font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The operating loss amounted to US$15.3 million compared to an operating loss of US$6.5 million in the first nine months of 2023. This change was mainly due to the decrease in other income</font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and the expected increase in operating expenses from US$175.3 million in the first nine months of 2023 to US$198.7 million, offset by the above mentioned increase in gross profit in the first nine months of 2024. The first nine months of 2023 operating expenses included milestone payments for Joenja&#174; of US$10.5 million in the second quarter. The increase in operating expenses in the first nine months of 2024 was caused by a combination </font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of continuing investments in Joenja</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#174;</font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> in the U.S., launch preparation for leniolisib outside of the U.S., increasing R&#38;D investments to expand the leniolisib franchise</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and increased payroll expenses due to business growth. Excluding the one time proceeds from the PRV sale and the milestone payment expenses for Joenja&#174; in the first nine months of 2023</font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the operating loss decreased from </font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">US$17.1 million</font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> to </font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">US$15.3 million</font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> in the first nine months of the current year.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The net finance result amounted to a gain of US$1.4 million compared to a loss of US$2.6 million in the first nine months of 2023. This was primarily driven by a fair value gain of US$5.2 million</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">upon the reclassification of the convertible bond-related derivative to equity. This fair value gain was a result of the decrease in value of the option component classified as a derivative from issuance until the physical settlement date of the newly issued convertible bond</font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. In addition, interest income from investments in marketable securities, which commenced in the second quarter of 2023, increased by US$1.7 million. These positive results were partially offset by US$1.1 million higher interest expense on the 2024 issued convertible bond and unfavorable EUR&#47;USD exchange rate developments, which led to a foreign currency loss of US$1.3 million compared to a loss of US$0.1 million in the first nine months of 2023.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company had a net loss of US$14.7 million, compared to a net loss of US$7.4 million</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in the first nine months of 2023. In addition to the support in other income from the PRV and the milestone payments for Joenja&#174; in the first nine months of 2023</font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, t</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">he change was mainly due to an increase in gross profit, higher interest income and the fair value gain upon the reclassification of the convertible bond-related derivative to equity, offset by an increase in operating expenses</font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, unfavorable EUR&#47;USD exchange rate developments and higher interest expenses on the 2024 issued convertible bond.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Cash and cash equivalents, including restricted cash and marketable securities, decreased from </font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">US$215.0 million</font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> at the end of </font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2023</font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> to </font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">US$173.3 million</font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> at the end of September 2024. This decrease </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#59595b;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><img alt="logo_pharmingxoriginal.jpg" src="logo_pharmingxoriginal.jpg" style="height:71px;margin-bottom:5pt;vertical-align:text-bottom;width:210px"></div></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">was primarily driven by the repurchase of the outstanding convertible bonds amounting to </font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">US$134.9 million and paid taxes of US$13.9 million,</font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> offset by net proceeds of </font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">US$104.5 million</font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> for newly issued convertible bonds.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On 5 October 2023, Orchard Therapeutics Plc. (Orchard) announced it had entered into a definitive agreement with Japanese company Kyowa Kirin Co. LTD for the acquisition of Orchard. During the first nine months of 2024, Pharming received US$2.0 million in cash for its shares held in Orchard. Pharming has terminated the research collaboration &#38; licensing agreement with Orchard Therapeutics and discontinued the OTL-105 program.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Outlook&#47;Summary</font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For the remainder of </font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2024 and the full year, the Company anticipates</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.03pt">Total revenues between US$280 million and US$295 million (14% to 20% growth).</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Continued progress finding additional APDS patients in the U.S., supported by family testing and VUS validation efforts, and subsequently converting patients to paid Joenja&#174; (leniolisib) therapy.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Increasing leniolisib ex-U.S. revenues - through our Named Patient Program and other funded early access programs in key global markets.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Completion of leniolisib clinical trials to support regulatory filings for approval in Japan and pediatric label expansion in key global markets.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Progress towards regulatory approvals for leniolisib in the EEA, Canada and Australia.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Advancing the Phase II clinical trial for leniolisib in PIDs with immune dysregulation linked to PI3K&#948; signaling to significantly expand the long-term commercial potential of leniolisib.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Continued focus on potential acquisitions and in-licensing of clinical stage opportunities in rare diseases. Financing, if required, would come via a combination of our strong balance sheet and access to capital markets. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No further specific financial guidance for </font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2024</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> is provided. </font></div><div style="margin-top:3pt"><font><br></font></div><div><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Additional information</font></div><div><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Presentation</font></div><div style="text-align:justify"><font style="color:#6d6d6d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The conference call presentation is available on the Pharming.com website from 07&#58;30 CEST today.</font></div><div style="padding-right:13.5pt;text-align:justify"><font><br></font></div><div><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Conference Call</font></div><div style="text-align:justify"><font style="color:#6d6d6d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The conference call will begin at 13&#58;30 CEST&#47;07&#58;30 EDT on Thursday, October 24. A transcript will be made available on the Pharming.com website in the days following the call.</font></div><div style="padding-right:13.5pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#6d6d6d;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Please note, the Company will only take questions from dial-in attendees.</font></div><div style="padding-right:13.5pt;text-align:justify"><font><br></font></div><div><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Webcast Link&#58; </font></div><div style="text-align:justify"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">https&#58;&#47;&#47;edge.media-server.com&#47;mmc&#47;p&#47;yotjk8ib</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Conference call dial-in details&#58;</font></div><div style="text-align:justify"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">https&#58;&#47;&#47;register.vevent.com&#47;register&#47;BId118ac68d9124f67b1a83e3769559100</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Additional information on how to register for the conference call&#47;webcast can be found on the Pharming.com website.</font></div><div style="padding-right:13.5pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#59595b;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><img alt="logo_pharmingxoriginal.jpg" src="logo_pharmingxoriginal.jpg" style="height:71px;margin-bottom:5pt;vertical-align:text-bottom;width:210px"></div></div><div><font style="color:#116a9e;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">For further public information, contact&#58;</font></div><div style="text-align:justify"><font style="color:#6d6d6d;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Pharming Group N.V., Leiden, the Netherlands</font></div><div style="text-align:justify"><font style="color:#6d6d6d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Michael Levitan, VP Investor Relations &#38; Corporate Communications</font></div><div style="text-align:justify"><font style="color:#6d6d6d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">T&#58; +1 (908) 705 1696</font></div><div style="text-align:justify"><font style="color:#6d6d6d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">E&#58; investor&#64;pharming.com</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#6d6d6d;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">FTI Consulting, London, UK</font></div><div style="text-align:justify"><font style="color:#6d6d6d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Victoria Foster Mitchell&#47;Alex Shaw</font></div><div style="text-align:justify"><font style="color:#6d6d6d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">T&#58; +44 203 727 1000</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#6d6d6d;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">LifeSpring Life Sciences Communication, Amsterdam, the Netherlands</font></div><div style="text-align:justify"><font style="color:#6d6d6d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Leon Melens</font></div><div style="text-align:justify"><font style="color:#6d6d6d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">T&#58; +31 6 53 81 64 27</font></div><div style="text-align:justify"><font style="color:#6d6d6d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">E&#58; pharming&#64;lifespring.nl</font></div><div><font><br></font></div><div><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">About Pharming Group N.V.</font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Pharming Group N.V. (EURONEXT Amsterdam&#58; PHARM&#47;Nasdaq&#58; PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For more information, visit </font><font style="background-color:#ffffff;color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">www.pharming.com</font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and find us on </font><font style="background-color:#ffffff;color:#00629a;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">LinkedIn</font><font style="background-color:#ffffff;color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Auditor&#8217;s involvement</font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Condensed Consolidated Interim Financial Statements have not been audited by the Company&#8217;s statutory auditor.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Forward-looking Statements</font></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">This press release may contain forward-looking statements. Forward-looking statements are statements of future expectations that are based on management&#8217;s current expectations and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance, or events to differ materially from those expressed or implied in these statements. These forward-looking statements are identified by their use of terms and phrases such as &#8220;aim&#8221;, &#8220;ambition&#8221;, &#8216;&#8216;anticipate&#8217;&#8217;, &#8216;&#8216;believe&#8217;&#8217;, &#8216;&#8216;could&#8217;&#8217;, &#8216;&#8216;estimate&#8217;&#8217;, &#8216;&#8216;expect&#8217;&#8217;, &#8216;&#8216;goals&#8217;&#8217;, &#8216;&#8216;intend&#8217;&#8217;, &#8216;&#8216;may&#8217;&#8217;, &#8220;milestones&#8221;, &#8216;&#8216;objectives&#8217;&#8217;, &#8216;&#8216;outlook&#8217;&#8217;, &#8216;&#8216;plan&#8217;&#8217;, &#8216;&#8216;probably&#8217;&#8217;, &#8216;&#8216;project&#8217;&#8217;, &#8216;&#8216;risks&#8217;&#8217;, &#8220;schedule&#8221;, &#8216;&#8216;seek&#8217;&#8217;, &#8216;&#8216;should&#8217;&#8217;, &#8216;&#8216;target&#8217;&#8217;, &#8216;&#8216;will&#8217;&#8217; and similar terms and phrases. Examples of forward-looking statements may include statements with respect to timing and progress of Pharming's preclinical studies and clinical trials of its product candidates, Pharming's clinical and commercial prospects, and Pharming's expectations regarding its projected working capital requirements and cash resources, which statements are subject to a number of risks, uncertainties and assumptions, including, but not limited to the scope, progress and expansion of Pharming's clinical trials and ramifications for the cost thereof&#59; and clinical, scientific, regulatory, commercial, competitive and technical developments. In light of these risks and uncertainties, and other risks and uncertainties that are described in Pharming's 2023 Annual Report and the Annual Report on Form 20-F for the year ended December 31, 2023, filed with the U.S. Securities and Exchange Commission, the events and circumstances discussed in such forward-looking statements may not occur, and Pharming's actual results could differ materially and adversely from those anticipated or implied thereby. All forward-looking statements contained in this press release are expressly qualified in their </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#59595b;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><img alt="logo_pharmingxoriginal.jpg" src="logo_pharmingxoriginal.jpg" style="height:71px;margin-bottom:5pt;vertical-align:text-bottom;width:210px"></div></div><div style="text-align:justify"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">entirety by the cautionary statements contained or referred to in this section. Readers should not place undue reliance on forward-looking statements. Any forward-looking statements speak only as of the date of this press release and are based on information available to Pharming as of the date of this release. Pharming does not undertake any obligation to publicly update or revise any forward-looking statement as a result of new information, future events or other information.</font></div><div><font><br></font></div><div><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Inside Information</font></div><div><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">This press release relates to the disclosure of information that qualifies, or may have qualified, as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#59595b;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><img alt="logo_greyxoriginalx.jpg" src="logo_greyxoriginalx.jpg" style="height:48px;margin-bottom:5pt;vertical-align:text-bottom;width:200px"></div></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font><br></font></div><div id="ia539f3d4cede4c79844ea01b8e3be3da_7"></div><div style="margin-top:3pt;text-align:justify"><font><br></font></div><div style="margin-top:3pt;text-align:justify"><font style="color:#116a9e;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:115%">Pharming Group N.V.</font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font style="color:#59595b;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Condensed Consolidated Interim Financial Statements in US Dollars (unaudited)</font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font style="color:#6d6d6d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">For the period ended September&#160;30, 2024</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#6d6d6d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#6d6d6d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Condensed consolidated interim statement of income</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#6d6d6d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#6d6d6d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Condensed consolidated interim statement of comprehensive income</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#6d6d6d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#6d6d6d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Condensed consolidated interim balance sheet</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#6d6d6d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#6d6d6d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Condensed consolidated interim statement of changes in equity</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#6d6d6d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:line-through">&#8226;</font><font style="color:#6d6d6d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Condensed consolidated interim statement of cash flows</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#59595b;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><div id="ia539f3d4cede4c79844ea01b8e3be3da_10"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><img alt="logo_pharmingxoriginal.jpg" src="logo_pharmingxoriginal.jpg" style="height:71px;margin-bottom:5pt;vertical-align:text-bottom;width:210px"></div></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:33.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONDENSED CONSOLIDATED INTERIM STATEMENT OF INCOME</font></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#376092;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the period ended September 30</font></td></tr><tr style="height:15pt"><td colspan="15" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#00629a;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#FFFFFF;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts in US$ &#8216;000</font></td><td colspan="3" style="background-color:#55b0e4;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#FFFFFF;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3Q 2024</font></td><td colspan="3" style="background-color:#00629a;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#FFFFFF;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3Q 2023</font></td><td colspan="3" style="background-color:#55b0e4;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#FFFFFF;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9M 2024</font></td><td colspan="3" style="background-color:#00629a;border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#FFFFFF;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9M 2023</font></td></tr><tr><td colspan="3" style="background-color:#f1f1f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">74,849</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#f1f1f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">66,661</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">204,528</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f1f1f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">164,099</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f1f1f2;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Costs of sales</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6,819)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8,295)</font></td><td style="background-color:#ffffff;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(23,186)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(18,094)</font></td><td style="background-color:#ffffff;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#f1f1f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross profit</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68,030</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#f1f1f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">58,366</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">181,342</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f1f1f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">146,005</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f1f1f2;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">777</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">304</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,034</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22,811</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,721)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,753)</font></td><td style="background-color:#ffffff;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60,839)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,287)</font></td><td style="background-color:#ffffff;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,292)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,886)</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,999)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,849)</font></td><td style="background-color:#ffffff;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing and sales</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,686)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,123)</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91,863)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86,136)</font></td><td style="background-color:#ffffff;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Operating Costs</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(64,699)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(56,762)</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(198,701)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(175,272)</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#f1f1f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating profit (loss)</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,108</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f1f1f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,908</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f1f1f2;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(15,325)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f1f1f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6,456)</font></td><td style="background-color:#f1f1f2;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value gain (loss) on revaluation</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,159&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other finance income</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,251</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,760&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,050&#160;</font></td><td style="background-color:#ffffff;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other finance expenses</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,998)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,488)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,621)</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance result, net</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,152)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,884</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,431</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,571)</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Share of net profits (loss) in associates using the equity method</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(442)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(485)</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,276)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(954)</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#f1f1f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Profit (loss) before tax</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,514</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,307</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f2f2f2;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(15,170)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f1f1f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9,981)</font></td><td style="background-color:#f1f1f2;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax credit (expense)</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,548)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,556&#160;</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#646363;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #646363;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Profit (loss) for the period</font></td><td colspan="2" style="background-color:#646363;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #646363;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,034)</font></td><td style="background-color:#646363;border-top:0.25pt solid #646363;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#646363;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #646363;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,464</font><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#646363;border-top:0.25pt solid #646363;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#646363;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #646363;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(14,700)</font></td><td style="background-color:#646363;border-top:0.25pt solid #646363;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#646363;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #646363;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,425)</font></td><td style="background-color:#646363;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #646363;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #646363;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share (US$)</font></td><td colspan="3" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #646363;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#006299;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.002)</font></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #646363;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.005</font></td><td colspan="3" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #646363;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#006299;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.022)</font></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #646363;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.011)</font></td><td style="background-color:#ffffff;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #646363;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:0.25pt solid #9d9d9c;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share (US$)</font></td><td colspan="3" style="background-color:#e3f2fb;border-bottom:0.25pt solid #9d9d9c;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#006299;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.002)</font></td><td colspan="3" style="border-bottom:0.25pt solid #9d9d9c;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.005</font></td><td colspan="3" style="background-color:#e3f2fb;border-bottom:0.25pt solid #9d9d9c;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#006299;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.022)</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:0.25pt solid #9d9d9c;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.011)</font></td><td style="background-color:#ffffff;border-bottom:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:center"><font><br></font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:center"><font><br></font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:center"><font><br></font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:center"><font><br></font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:center"><font><br></font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:center"><font><br></font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:center"><font><br></font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:center"><font><br></font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#59595b;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><div id="ia539f3d4cede4c79844ea01b8e3be3da_13"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><img alt="logo_pharmingxoriginal.jpg" src="logo_pharmingxoriginal.jpg" style="height:71px;margin-bottom:5pt;vertical-align:text-bottom;width:210px"></div></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.848%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.166%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONDENSED CONSOLIDATED INTERIM STATEMENT OF COMPREHENSIVE INCOME</font></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#376092;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the period ended September 30</font></td></tr><tr style="height:15pt"><td colspan="15" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#00629a;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#FFFFFF;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts in US$ &#8216;000</font></td><td colspan="3" style="background-color:#55b0e4;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#FFFFFF;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3Q 2024</font></td><td colspan="3" style="background-color:#00629a;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#FFFFFF;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3Q 2023</font></td><td colspan="3" style="background-color:#55b0e4;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#FFFFFF;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9M 2024</font></td><td colspan="3" style="background-color:#00629a;border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#FFFFFF;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9M 2023</font></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Profit (loss) for the period</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,034)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,464</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f2f2f2;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(14,700)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,425)</font></td><td style="background-color:#f2f2f2;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation differences</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,883&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,158)</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,352)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,079)</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Items that may be subsequently reclassified to profit or loss</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,883</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,158)</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,352)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,079)</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value remeasurement investments</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419&#160;</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Items that shall not be subsequently reclassified to profit or loss</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">281</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">79</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">419</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other comprehensive income (loss), net of tax</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,884</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,877)</font></td><td style="background-color:#f2f2f2;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,273)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,660)</font></td><td style="background-color:#f2f2f2;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#646363;border-bottom:0.25pt solid #9d9d9c;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total comprehensive income (loss) for the period</font></td><td colspan="2" style="background-color:#646363;border-bottom:0.25pt solid #9d9d9c;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,850</font><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#646363;border-bottom:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#646363;border-bottom:0.25pt solid #9d9d9c;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,413)</font></td><td style="background-color:#646363;border-bottom:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#646363;border-bottom:0.25pt solid #9d9d9c;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(15,973)</font></td><td style="background-color:#646363;border-bottom:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#646363;border-bottom:0.25pt solid #9d9d9c;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9,085)</font></td><td style="background-color:#646363;border-bottom:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#59595b;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div><div id="ia539f3d4cede4c79844ea01b8e3be3da_16"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><img alt="logo_pharmingxoriginal.jpg" src="logo_pharmingxoriginal.jpg" style="height:71px;margin-bottom:5pt;vertical-align:text-bottom;width:210px"></div></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.634%"><tr><td style="width:1.0%"></td><td style="width:59.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.634%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.636%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONDENSED CONSOLIDATED INTERIM BALANCE SHEET</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#00629a;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#FFFFFF;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts in US$ &#8216;000</font></td><td colspan="3" style="background-color:#55b0e4;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2024</font></td><td colspan="3" style="background-color:#00629a;border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#FFFFFF;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-current assets</font></td><td colspan="3" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,096&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,267&#160;</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,692&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,689&#160;</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,975&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,777&#160;</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term prepayments</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</font></td><td style="background-color:#ffffff;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,752&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,761&#160;</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment accounted for using the equity method</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,285&#160;</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in equity instruments designated as at FVTOCI</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,020&#160;</font></td><td style="background-color:#ffffff;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in debt instruments designated as at FVTPL</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,150&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,093&#160;</font></td><td style="background-color:#ffffff;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,548&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,528&#160;</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total non-current assets</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">143,322</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">146,512</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f2f2f2;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current assets</font></td><td colspan="3" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,227&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,760&#160;</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade and other receivables</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,199&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,158&#160;</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,104&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,683</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,662&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,741&#160;</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current assets</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">282,192</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">316,342</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f2f2f2;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#646363;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</font></td><td colspan="2" style="background-color:#646363;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">425,514</font><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#646363;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#646363;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">462,854</font><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#646363;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity</font></td><td colspan="3" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share capital</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,750&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,669&#160;</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share premium</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487,079&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478,431&#160;</font></td><td style="background-color:#ffffff;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other reserves</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,334&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,057)</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(278,371)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(265,262)</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shareholders&#8217; equity</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">225,792</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">218,781</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f2f2f2;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-current liabilities</font></td><td colspan="3" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible bonds</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,099&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,598&#160;</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,784&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,507&#160;</font></td><td style="background-color:#ffffff;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total non-current liabilities</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">119,883</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">166,105</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f2f2f2;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current liabilities</font></td><td colspan="3" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible bonds</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,319&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,824&#160;</font></td><td style="background-color:#ffffff;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade and other payables</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,638&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,528&#160;</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,882&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,616&#160;</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current liabilities</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">79,839</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">77,968</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f2f2f2;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#646363;border-bottom:0.25pt solid #9d9d9c;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total equity and liabilities</font></td><td colspan="2" style="background-color:#646363;border-bottom:0.25pt solid #9d9d9c;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">425,514</font><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#646363;border-bottom:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#646363;border-bottom:0.25pt solid #9d9d9c;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">462,854</font><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#646363;border-bottom:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font><br></font></div><div id="ia539f3d4cede4c79844ea01b8e3be3da_19"></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#59595b;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><img alt="logo_pharmingxoriginal.jpg" src="logo_pharmingxoriginal.jpg" style="height:71px;margin-bottom:5pt;vertical-align:text-bottom;width:210px"></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.008%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.865%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.865%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.865%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONDENSED CONSOLIDATED INTERIM STATEMENT OF CHANGES IN EQUITY</font></td></tr><tr><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the period ended September 30</font></td></tr><tr><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Attributable&#160;to&#160;owners&#160;of&#160;the&#160;parent</font></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#00629a;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#FFFFFF;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts in US$ &#8216;000</font></td><td colspan="3" style="background-color:#00629a;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#FFFFFF;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Share capital</font></td><td colspan="3" style="background-color:#00629a;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#FFFFFF;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Share premium</font></td><td colspan="3" style="background-color:#00629a;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#FFFFFF;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other reserves</font></td><td colspan="3" style="background-color:#00629a;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#FFFFFF;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated deficit</font></td><td colspan="3" style="background-color:#00629a;border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#FFFFFF;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total equity</font></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at January 1, 2023</font></td><td colspan="2" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,509</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f2f2f2;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">462,297</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f2f2f2;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8,737)</font></td><td style="background-color:#f2f2f2;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(256,431)</font></td><td style="background-color:#f2f2f2;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">204,638</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f2f2f2;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Profit (loss) for the period</font></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,425)</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,425)</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves</font></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) for the period</font></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,660)</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,660)</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total comprehensive income (loss) for the period</font></td><td colspan="2" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f2f2f2;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f2f2f2;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,660)</font></td><td style="background-color:#f2f2f2;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,425)</font></td><td style="background-color:#f2f2f2;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9,085)</font></td><td style="background-color:#f2f2f2;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other reserves</font></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(518)</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit from excess tax deductions related to share-based payments</font></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574&#160;</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574&#160;</font></td><td style="background-color:#ffffff;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</font></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,935&#160;</font></td><td style="background-color:#ffffff;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,935&#160;</font></td><td style="background-color:#ffffff;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised &#47; LTIP shares issued</font></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</font></td><td style="background-color:#ffffff;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,686&#160;</font></td><td style="background-color:#ffffff;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,947)</font></td><td style="background-color:#ffffff;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,880&#160;</font></td><td style="background-color:#ffffff;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value of conversion rights of convertible bonds</font></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total transactions with owners, recognized directly in equity</font></td><td colspan="2" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">141</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f2f2f2;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,686</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f2f2f2;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(518)</font></td><td style="background-color:#f2f2f2;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,080</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f2f2f2;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,389</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f2f2f2;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#646363;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2023</font></td><td colspan="2" style="background-color:#646363;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,650</font><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#646363;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#646363;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">475,983</font><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#646363;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#646363;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(10,915)</font></td><td style="background-color:#646363;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#646363;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(262,776)</font></td><td style="background-color:#646363;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#646363;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">209,942</font><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#646363;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at January 1, 2024</font></td><td colspan="2" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,669</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f2f2f2;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">478,431</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f2f2f2;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,057)</font></td><td style="background-color:#f2f2f2;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(265,262)</font></td><td style="background-color:#f2f2f2;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">218,781</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f2f2f2;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Profit (loss) for the period</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,700)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,700)</font></td><td style="background-color:#e3f2fb;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,560&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,560)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#e3f2fb;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) for the period</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,273)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,273)</font></td><td style="background-color:#e3f2fb;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total comprehensive income (loss) for the period</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">287</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(16,260)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(15,973)</font></td><td style="background-color:#e3f2fb;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other reserves</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#e3f2fb;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit from excess tax deductions related to share-based payments</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(241)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(241)</font></td><td style="background-color:#e3f2fb;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,605&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,605&#160;</font></td><td style="background-color:#e3f2fb;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised &#47; LTIP shares issued</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,648&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,244)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,485&#160;</font></td><td style="background-color:#e3f2fb;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value of conversion rights of convertible bonds</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,135&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,135&#160;</font></td><td style="background-color:#e3f2fb;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total transactions with owners, recognized directly in equity</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">81</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,648</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,104</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,151</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22,984</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e3f2fb;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#646363;border-bottom:0.25pt solid #9d9d9c;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2024</font></td><td colspan="2" style="background-color:#646363;border-bottom:0.25pt solid #9d9d9c;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,750</font><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#646363;border-bottom:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#646363;border-bottom:0.25pt solid #9d9d9c;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">487,079</font><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#646363;border-bottom:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#646363;border-bottom:0.25pt solid #9d9d9c;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,334</font><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#646363;border-bottom:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#646363;border-bottom:0.25pt solid #9d9d9c;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(278,371)</font></td><td style="background-color:#646363;border-bottom:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#646363;border-bottom:0.25pt solid #9d9d9c;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">225,792</font><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#646363;border-bottom:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#59595b;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div></div></div><div id="ia539f3d4cede4c79844ea01b8e3be3da_22"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><img alt="logo_pharmingxoriginal.jpg" src="logo_pharmingxoriginal.jpg" style="height:71px;margin-bottom:5pt;vertical-align:text-bottom;width:210px"></div></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.012%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONDENSED CONSOLIDATED INTERIM STATEMENT OF CASH FLOWS</font></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the period ended September 30</font></td></tr><tr style="height:15pt"><td colspan="15" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#00629a;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#FFFFFF;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts in $&#8217;000</font></td><td colspan="3" style="background-color:#55b0e4;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#FFFFFF;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3Q 2024</font></td><td colspan="3" style="background-color:#00629a;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#FFFFFF;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3Q 2023</font></td><td colspan="3" style="background-color:#55b0e4;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#FFFFFF;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9M 2024</font></td><td colspan="3" style="background-color:#00629a;border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#FFFFFF;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9M 2023</font></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Profit (loss) before tax</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,514</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f1f1f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,307</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f1f1f2;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(15,170)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9,981)</font></td><td style="background-color:#f2f2f2;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Adjustments to reconcile net profit (loss) to net cash used in operating activities&#58;</font></td><td colspan="3" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation, amortization, impairment of non-current assets</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,743&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,902&#160;</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,371&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,370&#160;</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity settled share based payments</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,965&#160;</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,605&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,935&#160;</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value loss (gain) on revaluation</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,159)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on disposal from PRV sale</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,080)</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other finance income</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,251)</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,117)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,050)</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other finance expenses</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,315&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(633)</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,765&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,621&#160;</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of net result in associates using the equity method</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,276&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">954&#160;</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,055&#160;</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,130)</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating cash flows before changes in working capital</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,729</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f1f1f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,830</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f1f1f2;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,571</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(14,361)</font></td><td style="background-color:#f2f2f2;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Changes in working capital&#58;</font></td><td colspan="3" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,133)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(396)</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,248)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,113)</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade and other receivables</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,919&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,363)</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,044)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,902)</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payables and other current liabilities</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,560&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,242&#160;</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,305&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,075&#160;</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363&#160;</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total changes in working capital</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,346</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f1f1f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,563)</font></td><td style="background-color:#f1f1f2;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,987)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(15,577)</font></td><td style="background-color:#f2f2f2;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest received</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,784&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,154&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,059&#160;</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes received (paid)</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,117)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,864)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flows generated from (used in) operating activities</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,742</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f1f1f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,527</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f1f1f2;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(11,126)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(28,879)</font></td><td style="background-color:#f2f2f2;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditure for property, plant and equipment</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(366)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147)</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(660)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,133)</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds on PRV sale</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,080&#160;</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment intangible assets</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposal of investment designated as at FVOCI</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,972&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of marketable securities</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109,796)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(144,554)</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(222,249)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(231,901)</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of marketable securities</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,504&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,451&#160;</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262,345&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,451&#160;</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flows generated from (used in) investing activities</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,350</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f1f1f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(58,227)</font></td><td style="background-color:#f1f1f2;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41,408</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(125,480)</font></td><td style="background-color:#f2f2f2;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of lease liabilities</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(918)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,007)</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,485)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,022)</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interests on lease liabilities</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(258)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(270)</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(784)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(825)</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net proceeds of issued convertible bonds</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(263)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,539&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of convertible bonds</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134,931)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interests on convertible bonds</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,029)</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,032)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,052)</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement of share based compensation awards</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,546&#160;</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,485&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,880&#160;</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flows generated from (used in) financing activities</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,433)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f1f1f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,240</font><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f1f1f2;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(32,208)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f2f2f2;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(19)</font></td><td style="background-color:#f2f2f2;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase (decrease) of cash</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,659</font><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49,460)</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,926)</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(154,378)</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange rate effects</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">861&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(913)</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">847&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,689&#160;</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at the beginning of the period</font></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,142&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,026&#160;</font></td><td style="border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#00629a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,741&#160;</font></td><td style="background-color:#e3f2fb;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#646363;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,342&#160;</font></td><td style="border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="background-color:#e3f2fb;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#646363;border-bottom:0.25pt solid #9d9d9c;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total cash and cash equivalents at September 30</font></td><td colspan="2" style="background-color:#646363;border-bottom:0.25pt solid #9d9d9c;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">60,662</font><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#646363;border-bottom:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#646363;border-bottom:0.25pt solid #9d9d9c;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">54,653</font><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#646363;border-bottom:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#646363;border-bottom:0.25pt solid #9d9d9c;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">60,662</font><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#646363;border-bottom:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#646363;border-bottom:0.25pt solid #9d9d9c;border-left:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">54,653</font><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#646363;border-bottom:0.25pt solid #9d9d9c;border-right:0.25pt solid #9d9d9c;border-top:0.25pt solid #9d9d9c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#59595b;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>logo_greyxoriginalx.jpg
<TEXT>
begin 644 logo_greyxoriginalx.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
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M?#4Y<Q6=UHVUGU^Z<)[G)KRCU!Y3SRF.ES(FT;ZSLM'IB>'?&,=Z9!Z>]U
M
M
M
M
M
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M-JZ3F<Q%YV5S-T3W6X1/XMT\<-\Z>CC.Y3
M
M
M
M
M
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MN8T3$QC#]"*
M
M
M
M
M                                           $6N7W+[9WA5L[>-X-
MX+Q["D@[J?%,4IW,6Z7^Z*Q7Q45%$]4[GNTU>]?5C;JYRHB'L_E+REK.=:R-
M/IXV\9X5CMG]L9G9#U3SEYRT7(]%.HU$[-T1&^T]D?MA$;9=>CS#Y?[N<U]Y
M[[O%NS=7/DJ7208=B$4CG6W'K0DKGPT-&Q4:G:Q%U?(J(Z1^KW=5/T!\H>4=
M)R71QI\B/3/&T\9G_#A&R'YS><_.6LYYKK:G43_#7A6O"(]\\9VRBN>T/4P
M          :2_$!YDW;'LL'%[EAD<M3LYK'2;7;JU3GS2XHJJC(Z"O=ZSG6W
MKI%)U6F_!7^!T]CQSZN='_ZWQ:W0U_6WVI'S]\?B[8^;^+?R:Z-=:OZ#PZ'7
MV_1W4O/R=T_A[)^7^'[NRBDJZ2X4E+7T%5'6T-;&R:BK87MDBFBD:CV/8]BJ
MCFN145%1=%0X>WI-9PG9,.:E+Q:(F)QB7D&6@
M
M
M
M
M
M      "-_*OE7L_PYV?OV\V\U^2V6*V)[&R62'L?<[W<WL<Z&@H(7.;[2:3M
M7Y4:QJ*]ZM8USD]C\K>5M9SC61I]/&-IWSPK'&9GA$?;NC:]9\V^;=%R716U
M.IMA6-T<;3PB(XS/V;YPB'7N\X^;6['.S>JX[L;E3):[11-?1[=;>T\KY+?C
MUI]HKVP1=R-]I,]='5$ZM1TC_D:QK&,Y^^2?)>DY'HHR,G;,[;6XVGM]'9'"
M._&9_.GSYYYU?/\ 73J,[96-E:QNK'9'?VSQGNPB(;'N#TL
M!H;\1OF1N7&M^.<:^3-RGOFP-3/'383N#*^2:LPE)55J12M[7NGMO<J>JB]T
M":JSN9HQ./W5CH_7F7BUFCC#4;[5X7_PM_NXX3M<C>CW6FW+/#HM;,SI\<*V
MXY?=WU^VO#&-C:E;+G;;W;;?>;-<(+O9[O!%56JZTLL=1355-41I+%+%+$KF
MO8]KD<US55%1=4Z'#/-RK4M-;1A,;)B=\2YOY6;6]8M68FLQC$QNF.V'G&'4
M
M
M
M
M
M                            X,Y(<B]K.*FS^6;V[PWY+)A^*1:I"SV;
MJVY5LB*D%#11/<SVM3.Y.UC-43TN<K6-<Y/.>7?+VJYKJZZ;3QC>WLB.,SV1
M'[;7@?,WF72<IT5M5J+84K[9GA$1QF>'V[,77P\^.?&[O/C=V?/,\G=8<&L+
MIX-K=K8)W24%AH)')JJKHU)JN9&M6HJ%:BO5$1$;&UC&\_/(GD32<ATGY65M
MO/WK<;3[HCA'#TXR_.KJ#U!UGF'6?FYOPY=?N4X5CWS/&>/=$1$05/>'H0
M              OL\2WF"R/B?=K#L#R#N]1DG&.Y3>PL=Z>U]37X/-42=WM8
M>U'22V]7.59J=-5CU62)->Z.3X3U6Z1Y?-:3JM+$5U,;XW1?T]ENR>.Z>$QR
M!Z0=9<WE%ZZ35S-M+.Z=\Y??';7MCAOCC$[>K'?++D]EM.28W=J:_P"/W^F@
MK+'?*.>.II*RDJ8TFBFAEA5S'QO8Y'-<U51475#A5GY%\J\TO$Q:)PF)V3$Q
MPESJR,^F;2+TF+5M&,3&V)B=TQ/8]J=)U0
M
M
M
M
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MGS;9>;6:WK.$Q.R8ESQT6MR=3DUS<JT6I:,8F-L3'<^E.V=T
M
M
M
M
M
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MQ6>6',>"N2-VWW'^>YQQAR>I62[8W$[VU=C59,[5]PM;97-16N7K44VJ-?\
MAM5'Z]_Q[JCTJR>>9?YV3A34UC9/"T=EO=/#=NW?:NDW5W.Y!F_DYV-]+:=L
M<:S]5??''?&W?NUV]W"PG=?"<9W'VXR:DS+!LRI(Z[&LEH9$EIJNFE3HYJ]%
M145%:]CD1S7(K7(CD5$X.<PY?GZ3/MDYU9K>LX3$[XG]O:Y\\NYCD:O(KG9-
MHOEWC&)C=,?M['V1V;O0
M
M
M
M
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MQ,?MO[8WQ.R7WQV#R
M
M
M
M
M                                    ?,YIFF)[=8GD.=YWD-)B>'8G
M235V29)73,IZ2CI*=BODEED>J(B(B?Y?0G4[G1Z/-U&;7*RJS:]IPB(WS+M=
M;K<G39-LW-M%:5C&9G9$1#!'Y3O*=FW/'-I,+PN2KPWC)AM6Y^'8<]RQ5-\J
M8E5C;K=6L546145?8PZJV%J_*]7.7G;TOZ7Y'(LC\S,PMJ;1MGA6/IKW=L\?
M1A#\_.K'5C/\P9_Y65C32TGX:\;3]5N_LCAZ<95#'UI\<
M          !:%XU/)QNAP%W!@HIYJO-N/.4U37;C;5^VU]DZ3MC=<K6DSD9#
M6QM:FJ:HR9J=C]%1DD?S+J1TTTO/M/C&%-16/AO_ "V[:_;&^.,3]4Z8=4M5
MY>U.$XWTUI^*G\U>RT>R=T\)C?7LYO+MGO\ [<8QNSM#EU+FN!Y=3MGL][I7
MZIU3UX9HW:/AGB=ZLL4B(]CD5KD14.!_..3ZG0:FV1GUFF96=L3^^.V)X3&R
M7Z$<EYUI>8Z:NHT]HOEVC9,?NGLF.,3MAR<>,>4
M
M
M
M
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M'N<T'AGFP
M
M
M
M
M                      /57R^67&++=LDR2[4U@Q^P4T]9?+Y63QTU)1TE
M-&LTLTTLRM8R-C&JYSG*B(B:J=7(R+YMXI2)FTSA$1MF9GA#I9^?3*I-[S%:
MUC&9G9$1&^9GL8:O+YY8KES(R2HV0V.NE79N,6)52_/*Q%DIILVN%/(BLK*F
M-4:]M%$YNM+ _JJZ2R(C^QL7-SI)TJKR?+_J=3$3J;1Z?!'9'XIXSZHV8S/
M[K)U=MSK-_I=+,QI:SZ/S)CC/X8^6/7.W"(HN/M[X*
M        !RYM-L#OAOS=7679?:/(MTKC$]K*J.QVBNN+*97::+42TT;HX6]4
MU=(YJ)\JGB>:\^T6AKXM1F5RX_%,1CZ,=_J>8Y/Y>U_,+^'395\R?PUF</3A
MN]:TW;#P#>1+<**"IR#$L;V>IJA$<QV39'3OD[%35%6+&X[M(U?^*]K51?2B
M'R_F?7GR]IYPI:V;/X:S_-X7U?E7]O7F34QC>M,J/Q6C]U?$F/C_ .S,;R5-
M.KLJY1XS9JK1-(;?8KK<X^[N75.^IGH%TTTZ]O\ [FJ^GZC^Y/1Q/P:>\QWV
MB/W1+W73_P!KVMF/U-32)[JS/[YA9GP)\2N__C]W)@RS;KF;29K@.5>SCW;V
MAK\+J:&VW.*-NC):>6.^U7LZN'N=[*?V:+IZKD<QRM/FWGOJOH.?Z;\O.TLT
MS*_<O%XF8]/P1LGC&/HV[7U#I_T@YCY=U7YF3JXOEV^_2:3$3WQ/CG"8X3AZ
M=FQ>P?#GWP
M
M
M
M
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M6FUIWS,XS/KE]TTNDRLC+BF76*UC=$1$1'HB'O3H.X
M
M
M
M
M                                                         ?G-
M-%3Q2U%1*V""!KGS3/<C6,8U.Y7.5VB(B(FJJI8B9G"$F8B,98O/,?Y>Z_?F
MYY-Q7XS9$M)L9:Y7T>Y.XM%-Z^93Q.[9*6EEB7I:V.317(O^L*FO\5IW\R.D
M'22NAK76ZRN.?.VM9^3OG\7^WT[N$G6GK';F%[:#16PT\;+6CY^Z/P?[O1OS
MEG(=QK                         !IA\7G@ON>ZU-8=^^:-GK<8VYJ495
M89L:]9[?=KY'KJVHNKFK'-24CD35D+5;-(B]RNC9I[3C;U-ZWUTLSI>73%LS
M=:^^*]U>$SW[H[YW<H.E706^KBNKYE$URM]<O=-N^W&([M\]T;]?.)XEBV!X
MW9L.PG'*'$<3QV!E-8<:MM+#14-'3L_!CA@IVL8QJ:^A$.).KU>;GYDYF9:;
M7MMF9G&9],RYCZ31Y6GRHR\JL5I6,(B(PB([HA]"=N[D
M
M
M
M
M
M_CG-8USG.1K6HJN<JZ(B)UU74#'5YG?+U)NE5Y#Q*XKY=_\ XMIO:T6\FZ%O
MD5/ZR3M<L<MKH)XW=;<W32>5O_.%U:U5A15FY>]'.DG]+%==K:_J[Z5GY?Q3
M'U=D?+O^]NX8=;.L?]7-N7Z"WZ6Z]X^;\-9^GMGYMWW?O9FCDFXO
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M)XUF)C[./=O?3'8/)@
M
M
M
M
M                   &1WS/^7^FRF')^'_%/*5DQ_OEH=[MW[=4:,N*-[HI
MK-;)H5]:GU]6JG:NDFBQL58^]7\L>CG2.<J:Z_75^+?2D\.RUH[?ICAOG;AA
MP]ZV]98S8MR[06^'=F7CCVTK/9]4\=T;,<<LQR?<40
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MWG\,SNG\,^J9W180?%7((
M
M
M
M
M                    #*MYG?,$VV-S7AMQ9OR.N;DJK1OONS2NU2E1>ZFJ
MK+;)$_SOX4=7.GX'6-GK]SF<H^CG2/Q>#F&MC9LG+I/'C%K=W&L<=\[-_$SK
M9UE\'CY;H;;=M<R\<.$TKW\+3PW1MQPR6G*UQ"
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M '&5R]
M
M
M
M
M   #,?YG?+[/M@[(N(W%?)VMW#GBDI-Y=VK?.BNQYK^Z.6TVZ6)?5KU3I43-
M7_5T7L:OMNY8>2W1SI)&I\.OUM?T]]*3\WXK?A[(^;?/P[^+?6SK).D\7+]!
M;]3=>\?+^&OXNV?EW1\7W<>KG.<Y7.57.<NKG+U554Y=.&;^
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MS\O?/XNR/E].[@WURZVSKIMR[06_1C9>\?/VUK^#MGYOX?O54G(EQ6
M        7'<)>>$B26;9S>^[-6%6QTN%;A5+U1R.1>R.EN$CUT5%31L<R^CH
MC]=>Y.+_ %8Z/QA;6Z"NW?>D?;-8_?7V=CF+T3Z[3C3E_,K;-D4S)^RMY^R+
M>JW:N6.+CF0
M
M
M
M
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MC*BO+^97^&-E,R>'96T]GTVX;IV83%T**CD1475%ZHJ>A4.*[F=$OZ
M
M
M
M
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ME'W=?K:]]*3_ +K1_MCU]CAUUVZUQA;EO+[]V9>/MI6?]TQZ(XJ;#E$X;@
M                MMX-\Y%QM;1LQO/=]<<7LIL'SBI?UMZ]&1T=9(]?^;_)
M'(O\7^"[U-%9QLZM])/S_%KM#7X]]Z1\W;:L?5VQQWQMW\M.A_7#^F\/+N8V
M_3W4O/R]E;3]/9/R[I^'[MVR*CD1475%ZHJ>A4.)[FS$OZ
M
M
M
M
M                                    41^7GRV6WAY9:_838RMAO')S
M):-KKA=E8R>DPJ@JX^Z.JF:]%9)72,7NIX%14:FDLB=O8R7[ETEZ46YO>-5J
M8PTU9W<;S'".RL<9]4<9CX%UCZP5Y+2=)I9QU5HVSPI$\9[;3PCUSLPB<.%W
MNUTO]UN=]OEQGO%[O51-5WB[U4KYZFJJJF1TTLTLDJJY[WO<KG.<JJJKJIS:
MRLJN72*UC"L1A$1NB(X."&=G7S+S>TS-IG&9G?,SOF7KSJ.F
M            %S_B=\4^5\WLQHMTMSZ*IQGBWA]:W\=714D@J<LJZ:1%?;+>
M].UR1:IVU52U?435C%]IJK/CG57JEE<DR9R,F8MJK1LCA2)^:>_LCCOG9O\
MMO2+I+G<]SHS\^)KI*3MGC>8^6O=]4\-T;=V[_&,8QS"L<L>(8A8Z7&<6QFE
M@H<>QZA@CIJ.BHZ:-(HH88HD:UC&-:B(B)HB'!G4ZG,SLR<S,F;6M.,S.V9F
M>,N?>ETN5D949>7$5I6,(B-D1$;HB'O3H.X   "HWG5S>BL<-ZV2V>NOM+[,
MCZ7/,UII%TH&KZDE%221KUG7JV61%_@^K4]?56<E>D/2:<V:Z_6U^#?2D\>R
MUH[.R..^=F_B1USZW1D1?EO+[?J3LS+Q\O;6L_5PM/R[H^+'PTFG*YPI
M                 6O<)N=E1B$EFV@WHNOML.5&4N(9O.Y5DM2Z]L=/5O<O
MK4WH:R1>L7H7^#ZLXY=5^D%=3%M;H:_J[[4CYNV:_B[8^;AMW\K>BG72VCFO
M+^8VQR=U+S\G96T_3V3\O'X?NWB,>R5C)(WI)'(B.CD:J*US535%14]**<2I
MB8G"7-^MHF,8?Z(H
M
M
M
M
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MCY/PU_'VS\O\7W:+7.<]SGO<KWO55<Y5U557JJJJG+N(P<&IG%_"H
M               6I\(><JX%^+=H=Y+LY^#^K#B&93N5SK.OH;35+EU5:7Y&
M/_S7H7^#_ X[]6>D?]9CK=%7];?:L?-WQ^+MCYO3OY3]$>N/]!X=!S"WZ&ZE
MY^3\-OP=D_+_  _=O,@GAJ88:FFF;44]0UKX)V.1['L>G<US7-U145%U14.(
MUZ36<)V3#G)2];5B8G&)?J9:
M
M
M
M
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M.=JJJJKJJJ<Q:4BL81LB' V][6M,S.,R_(TP
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ME!@DK:KQ:;[0P7.QW2FO-MJ41U-<:2>*H@D:J(J*V2%SFJFBZ]%"/8@
M        XJWSW5M^QNSNY>\5UM4U]MNVEEK[S76:G>R.>IBH('3NCC=)ZJ.<
MC=$5>@%&?_>']F?\.V3_ ,ZVK_S28M>$_P"\/[,_X=LG_G6U?^:,3PG_ 'A_
M9G_#MD_\ZVK_ ,T8GA/^\/[,_P"';)_YUM7_ )HQ/"MWX;<JL?YD[*4.]>,X
MI689:ZZXW"W,LE=-!45#7V^1L;GJ^GT;H[NZ(5E*H
M
M
M
M                      51^3_R?X!P%P!;'8UI<TY'YI2O=M[MZYZOAH(7
MJZ)+K=4B<CF4K'(OLX]4?.]%:U4:CWL^I],NF6HY]J/%;&NFK/Q6[?PU[^V=
MT1MGA$_).JG533^7M/X:X7U-X^&O9^*W=V1OM.R.,Q@2W#W#S7=C.,HW(W&R
M2JR_.,SK):[)<CK972U%54RKU557T-:B(UC4T:UJ(UJ(U$0YX\OY?DZ3(KDY
M-8K2L81$<(?GOS+F.?K,^V=G6FV9><9F=\S^WL?&G>.R
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M/X=UZ9Q$<Y@                   ,/_FM^T+W6_)F+?5VD)+=54(4
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M*$
M
M          %;G.SR:;)\(:6'';E32;D;R76G^<6;:^WU$4+J>%R:QSW.J<V1
M*2%_[SU'R/\ 2UBMU<A8AG7W*\Z'.7,KA52X5=<>VAMCW+\QHK58J2Y31QHN
MJ>TFR)*]'OTZ*Y&-1?D:A,6L'&5M\S7D8H:V"JJM^(+S!"NLEMJ<2PUD$J?<
M<M':H)-/^2] 8+(N,'G_ +A/>;9C/++;FCI;/62,BEW/Q:.J8M&CG(WVM7:Z
MB2H=*U->Y[H)$<B)ZL3EZ#%)JTJ8CEV,9[C%BS3"[[2Y/B>3TL5;C^044K9Z
M6KI9VH]DD;V*J*BHO^3T+U*R^B
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M,-]L[@J&[5;<.>OLU6/^#=<KBL2HZ.BA<NFB*CIGI[-BIH]\?TOIMTYU'/\
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M9[BY%^;I L.OD(V   &UGP9_ 5C_ +SY)])C*Q*X4(
M
M                                                 1[Y6;]VGC#Q
MYW5WSNT$=:F!6Q\UGM<KG-CK;K4R,HJ"F<K/61LU5-&QRIU1%5?D"Q#KV-Q-
MP<PW7SG*MR,_ODV1YEFE;/<,AO,[E<^:HG?W+HGH:QJ:-8QNC6-1&M1$1$(V
M^,   -$_@=Y@W?'=Q+KP_P QNKZK$<ZBK;MM/'*Y7_B^]T<+JRMI(NY?5BJJ
M>.2;M]"21JJ)K(Y5,S#5N5D
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MM=/IZ^'+KNCWSVS/&7YW<^Y]JN9ZJVIU-IMF6G;/NCLB.$.)3RKQ
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MJY>76*TK&$1&Z(?G?K]?G:K.MG9UIM>TXS,[9F9>I.Y=H
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MW*SW%R+\W2!8=?(1L   -K/@S^ K'_>?)/I,96)7"A
M
M                                                 "C7S^9-4VCA
MO@]AI)G1?UMSZTPW%B([LDI*2RW6M5KE1437VT<3D1=?1]XDM58ZPT   $H^
M$.45&&<Q>+N14\KH4I,]Q6*M<S57K25=YIZ.I:B(K=5=#*]NFNG7KT!+L.RN
MF
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MKGFJJJ9]34U+W25%1(Y7R22/57.<YSE55557554Z[RL1@_(*         /\
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M70+B@->+->,>N=;9;_:JFQWFW/6.X6FL@EIJJ"1$U5LD4S6O:[KZ%0*]8
M  $D^*O*G=7B#NQ:-UMK+JL51 K8,HQB9S_Q=?+8KT=+1U<;?2UVFK'IZS':
M.:J*@);RN,7)3;;EAL]C.\FV%>LUGO;?97>S3*U*VT7.)K5J*&J:WT2Q*Y.J
M='-5KVJK7(JUTY2!     "'GD&^![E9[BY%^;I L.OD(V   &UGP9_ 5C_O/
MDGTF,K$KA0@
M
M                 !4!YP]L;KN)P3O=YM,+JF3:7)+)D]=3,1SGNI&,JK#,
MY$;\D;;HLCON-:J_(%AB@(V   $\/&3MC==U>=G&RS6R%SX\7R2BR>ZU*([L
M@I,6?^/G.>J>A'.I6QIKZ7.1/E"2WW%8
M                                       !E7\AU=5\/_+ULSRKNU(]
M,(S=<>NMUN;&ND1:6AHF8=>(F-];66&BC9)VM33UV_*JD:C<MF\P%?177QH[
M_P!TME7'7VVY0X9/;Z^%[9(9X)LYL<D<C'L54<US5145.BH5(0A\.O&;8+?S
M@5F-MW;VEL.:37W+,@MU3?ZNV4;[O#3?BZW=GS>O]G\XA=&YZNC=&]%:[JG4
M$[U>GCQW)RC@;Y)\@XXY3>YXL%RS(Z_ <KIIG21TU35)6OI['<TB_!1SYO9(
MV1432*=_712-2M$\^6^MGQ/CAANPM'5QSYAN_>Z:NK+6B]TD5CL3EJ7RJC>K
M5?5K R/7\)$?I^"NB4JK\_4Y[B?]E*C_ -@?]9OP4_\ :A_^"_\ Z;[_ */O
MA<6NHK     (6\YN<VS_  0V?J]R]RZM+ID5T2:GVUVUIYF,N>17-C$=[*+N
M1WLX(^YKJBH<U6QM5.CGN8Q_N?DCR1J^>ZN,G)C"L;;6G=6/?,\(X^C&8](\
M^>?-%R#13GY\XVG96L;[3[HCC/#OF8B>O:Y1<G-UN7>\N4[V[OWE;EDF1/[+
M?:XG2I;[/;HW.6GH*&*5[_94\*.71NJJYRN>Y5>YSEY^^6/+6EY3HZZ;3QA6
MO'C,\9GMF?\ *-D/SH\U>:=7SG6VU6HG&UMT<*QPK$<(C_.=LRCV>P/70
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M,(B/V]L[YG;+\WN;\WU.OU-M1J+3?,O.,S/'_+A$1LB-D;'SAWSQH
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MZKY44\PZB(^J)]M8E^E'13.MF>5M+,_3,>RTQ'V0E,?/7U(
M    ,/\ YK?M"]UOR9BWU=I"2W55"%  '.O%WXF..WOUB/U@I 2[&DKI@
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MDGTF,K$KA0@
M
M                 !Z#*L7L.;XQD6&Y5;([UC.64-7;<AM$R:Q55%70.IIX
MGI_P7L>J+^Z!@^Y^\"-R.$NZ%QM];;JJ^[-9#52NVOW*]GW4]33OUE91U3XT
M[8JV%NK7L=V]_:KV)VKTC<2@"% /8VBSW;(+I;['8;747N]W>:.GM-GHX):F
MJJJB9R,CBBBA:Y[WN<J(UK4557T ;.?$;X[KGQ$P>[[J[M4D<6^^Z-)#!4V9
MJLD_JW8^YE2V@5[=4=4S2-;)4JU5:BM8QOX+G.K$RN4"
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MW2Z7&]W&NN]WK9+C=+G*^>OKYGJ^6:61W<YSG.ZJJJIW+RM:Q$80\$-
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MUGP9_ 5C_O/DGTF,K$KA0@
M
M                              ]!E&*XQF]AN>*YECM#EF,WJ-8;OCUR
MI(*ZBJHE]+)8*EKV/;]Y44"K/<GPF\"]P:ZJN5MPJ];8558Y[ZAN-WR>&#O>
MU4]2GNS+A#&B*NJ-C8UJ:>C3H%Q<76;P$<)[75)45V6;A9'"BMUH:R^61D2Z
M+JJ:V^RTK^OH7UOW-!@>)89Q_P"#O%;C Z.LV9V<MF.9"R-T;LRJ$FNE[<U_
MX:)7W-\\[&O_ 'S(W-;\FFB(#%+ (
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MEVN%]OMPENMXNLKIKA<)G=TDLCO2JK_XD1.B)T3H=R\M6L1&$/5AH
M          -)?B \R;MCV6#B]RPR.6IV<UCI-KMU:ISYI<4551D=!7N]9SK;
MUTBDZK3?@K_ Z>QXY]7.C_\ 6^+6Z&OZV^U(^?OC\7;'S?Q;^371KK5_0>'0
MZ^WZ.ZEY^3NG\/9/R_P_=V44E727"DI:^@JHZVAK8V345;"]LD4T4C4>Q['L
M54<UR*BHJ+HJ'#V])K.$[)AS4I>+1$Q.,2\@RT               8?_ #6_
M:%[K?DS%OJ[2$ENJJ$*  .=>+OQ,<=O?K$?K!2 EV-)73
M*6/,AP0HN1>SM;OQ@%G[M[MEZ"6>>.!C?:W[&J=75-31O3HKY:9%?/3Z:JOK
MQHBK(W0L2QD$;   "QKQ3\@I>/7-?:BZ554M/BFY4_\ 4[-&:Z-6DOTT<%-(
MY55$1L-:VGE<JZ^JUWW0DPWB%8   "'GD&^![E9[BY%^;I L.OD(V   &UGP
M9_ 5C_O/DGTF,K$KA0@
M
M
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M/(-\#W*SW%R+\W2!8=?(1L   -K/@S^ K'_>?)/I,96)7"A
M
M
M
M                  #AGD!O[M?QBVER_>O>'($QW!L-@22NG:WVM34SR.2*
M"EI845%EJ)Y'(R-B*G5=55&HJIYCD'(=5S/5UTVGKXKV]D=LS/"(XO">8O,.
MEY5H[:G46\.72/7/9$1QF9V0Z^3R%<_MSN?N\DF<Y2U^,[=XPDU)M3MC'.Z2
MEM% ^3N=++IHV6MJ-&K43=J:Z-:FC&-1.?G3_P A:;D.C_*I\69;;>W&9]U8
MX1Z]\R_.OJ-U#U7F'6_FYGPY==E*<*Q[[3QGU;HA 4]\?/@
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M&R-\\;3QF>^?LW1L?FEYS\XZWGFOMJM3.,SNCA6O"L=T?;.V=LN*3V-ZH
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M54Y4Z:]EONT5.B:>GK5]?O>E6*>%;CQ]\E'#;DI4T5GP'>&CM.7U[FQTV"Y
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MX4]7'MGT0_//K)U(MSWF$Y>5/_C94S%>RT[IOZ^'9'?,JACZT^.
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MR,B.^UIWVGMGW1PA^:?GOSUK?,&OG4ZB>ZM8W5KV1[YWS/LCA<]J>E@
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M<[#'DR[/;7UBO9'M[C4\U,Z>G<NB,K[@G;452JG1[=61.]/LD(U$*Q0H
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MED4F6;O[C7C<6_O5WLJZZUT]6D#'N[ECIXY'>SACU]$<;6M3Y$#3C
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MSVZK&D;B%$5145%943U=7.^JJJI[I*FID<Y\DDCW*YSG.<JJKE5=55?2%?B
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M^.#67<G:?,*+.,*O[.ZW7RBD[V=R(G?%*QR(^*:-5TDBD:U[%Z.1%*RY%
M     X*Y1?#-R*]Q,N^K]6!URQ'4    !9#Q(\I7*;B?<+9;:3+)MT]K*56,
MK-K<BJ9JJF93M1&]M!5R>TGHG-;KV)&JQ(O5T3_0$F&Q#B+S'V;YG;<-S[:F
MZNCKK8L4&:X/6=C+K8ZV2/O2*HC:JHZ-^B^RF9JQZ(NB]S7-;69A*T(
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MJC_9GO3'#WW+:FZ5,;I*ES&JZ1]JJE2-M;&U&JY41K96HBJZ-&IW+69A9.$
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MR\B(MZ;?+'[[?\+X7U^\XVY9R;\G+G#-U$S6.V*_//LF*_\ $P>'.=P#
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MO6XVG_#LCAZ<9G\V.H/4'7>8M=.?GSA6-E*1NK'9';,\9WS/9$1$<#GN#T0
M               <0[S[R8SLQB<]_O<J5-UJDDCQO'FN1)ZZI:W5$3T]L;=4
M62331J?=<K6KNE,6JUFTX0HYS_/\GW,R>ORS+*]:ZYURZ,8FK8::%JJK(86*
MJ]D;->B?NJJJJJJ]S$8/+965%(PA\85U0                         :
MOV=OD+5[<<P,BV*KZU6XQR&L52RDH5<B,3(,:AEN]++ZW_[HE8Q43357-^XB
M'P3^X/R_&HY174Q'Q9-H_P"6VR?M\,N0_P#;?YCG3<YMI9GX,^L_\U<;1]GB
MCV-O)PJ<Z0            ,/_FM^T+W6_)F+?5VD)+=54(4  <Z\7?B8X[>_
M6(_6"D!+L:2NF                *[O+%]GIR7_ "9:_K%;PL,&1&P   UB
M?L\3*I-D.0<CV2)1ORJWM@D5'>R65MH:LB-5>G<B.9W:==%37Y!#-FAHK(
MAYY!O@>Y6>XN1?FZ0+#KY"-@  !M9\&?P%8_[SY)])C*Q+AWR:^7BU;!2W_8
M7C774^0[UP^TI,RSW2.IMV*2:(UT,+7(YE17MU5'-76.%W1Z.>CF-BQ#)+D^
M49'FN07C+,OOM7DV3Y!/)57R_P!=/+55=742KJZ26697.<Y?NJH:>B
M     '+6R&^6Z''3<>Q;K;0Y3-B69V!7)!6QHV2&HIY-$EIJF&1%9-!(B:/C
M>BIZ%31R(J!NLX*<V< YO[/P9YC<+<?S6P.BH]S< =*DDUIN+F*Y',<NBR4T
MZ-5T$FB:HBM71[7(E8F$V @          5-^0KRJ;8<-J6NV^PN*EW.Y"U$*
M+!B#9];=8?;,[HY[O) O<UVBH]M*U4D>U455C:YKU+$,=F^W(3>+DKG59N+O
M3G-9FV2U**RD=.Y&4E!3]W<E/1TT2-BIX47KV1M1%75RZN556-N&
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M*K9*R1JJB(BJV%JJQBKJ]\D;B%<P4     #7)^SU_#/O5[].^K]O$,V7]%9
M %9'F/\ LW^1GZ(?7RRA886"-@  !V*UXWVVUV8XWV+>W=+(8L0P:U8[:JVM
MJYU[I7.J*")\5-#&WUIIY'.1D<;$57.]!738W^?ODVW=YJWZMQN@FJ-O-@+?
M.BX[MG!+VRU_LG=S*J[RQ+I43*J(YL2+[*+1$:BN1TCXW$*R0H
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ML(W:V_N*77#\^M\%QL=5T1Z1S-]:*5J*O9+$]'1RL]+7M5J]4*PY%
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ME3#$B>AD-52K*[7]]/\ +\B&;-#960      $%?)I\!/*+W8G^DPA88"R-@
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M(86)ZL<,3$1D4;?5:U$1.B$;<;              _K7*U4<U5:YJZM<G145
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M7NM^3,6^KM(26ZJH0H  YUXN_$QQV]^L1^L%("78TE=,
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M-F-WZNJ;59#>[4RDS5R:(OX\M4CK97N5J(G;[2:!TK4_X+D5.BHI6)2V"
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MCR_=JYTZ1YEN]6T[$N%4K]'/@I&JK_FE)W(FD3%U=HBR.>Y$5*Q,I]!
M /29)C6.YC8;KBV6V&CRC&K["^GO6/W"FAK**KIY$T='-!4->Q[5^5'(J 95
MO)7X;ZO:NCON_'$RU55ZVYHV2U>=;1(]]776&%B.DDJ[<Z5RRU%&U$]>)5=+
M%U<BOCU]G&HEGE#0    /L-OL/K]P\^PC +4JI<\YO%LL]N5&]RI/<ZV.BCZ
M=-?6D3H!V3%@L=LQFQ67&[+3)1V?'Z2FH;31M_!BIJ2%L$3$^\UC$0KIO;
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M@VC=69KDTR(J^P98X=*%_P!S_P!8STK>OW3Y7UGYU&B\OYNWXLS"D?\ %O\
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M@Y3\?=QV2^QI\7RVR2W9W=V=UNFKHZ6M9W?)WT\LC=5Z=>NJ= DNQ.*P
M     .OD\@OQP<K/?O(OSC(1N$/ H  O3_9]OC+W,_W8WGZU8X(2S865@
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MR6[&;:KF8QCO?JRGB7HLC^WHZ:335[ODZ-3HB'=5KA#RF1D12.]P::=P
M                           &U3]G>XF5.UG'O,.3666Q:7*>051'386V
M5NDD.*6:62-DK4<B.;\\JW2.5%U1S(HG)T4X9_W!>:XU7,*Z/+GX<F,;?QS_
M (1AZYF'-_\ MP\H3I.77UV9&%\^<*_P5_ZIQ]41+1.<>W)$
M##_YK?M"]UOR9BWU=I"2W55"%  '.O%WXF..WOUB/U@I 2[&DKI@
M     *T.??DQVBX58]6V"CJ*;<'?NO@1V-[80SZMI/:Z=M5=9(=5IX41>YK.
MDDO1&HC55[2Q#$[O%O!N%OWN3E6[.Z>0R9-F^8U'SB[W.1$8U$:Q(HH88VZ-
MCABC:V..-J:-:B(A&W&0    UV^![BM-MMLME')/*[7\VRG>Y[:/"O:L5LT&
M+VZ9VLB=VBHE;4M5^FFBLBB<BZ.$,VE?B5D   (>>0;X'N5GN+D7YND"PZ^0
MC8   6L>)+A3%RUY#1W[-;4E;LMLPM+=L[AE8CJ>Z5KY%6WVMR.U[FSOB=),
MFBHL4;FKHKVA)EN$8QD3&1QL2..-$;'&U$1K6HFB(B)Z$0K#_0         !
M0%^T%;54V0<>-H]WZ>G[[MMMD[[753(U/5MF14+W2.<[TZ-J+? UJ?\ &4DM
M59'@T   '8'>.K+79MP9XM7MTJS/I\.M-LDE7JJNL</XD=JJHFJZTG5?_&OI
M*Q*: 0    %6?F9K[G!X_=V;3:(IZBMRBOQFA;2T\,TTLK&Y#25[VHD**J)V
MTR]RKT5-4^4+#$I_4G,_^R-S_P"@57^C(WB?U)S/_LC<_P#H%5_HP8G]2<S_
M .R-S_Z!5?Z,&)_4G,_^R-S_ .@57^C!BW)^(_ /]GG '8FAJ+<ZVW?(HKQ>
M;XR1GLY9)KC?*N2)SVZKHJ4Z1,Z]=&IJB+T*Q*R0(         /SEBBGBD@G
MC;-#,U630O1'->UR:*BHO145/2@'7*\F-LV[,\A][MJ88UBHL RF^6NTZ]%=
M0TMQECI7]?D?"C')^Z1U'!X  !>7X!<PELG,/-L5?.K:+-L&N;&TW<J(^LM]
MUMU9$[3T*K8DF1/W5Z_(J&;-B960      %<7EMQIF4^/3D;2+#[::V45HN=
M,Y.Q'1K;,BM]<]R+)T3^#C<BZ=5151.JA88/B-@  !;/X@^&%/RIY%LRO-K4
MVX;/;'K2W;+Z29BNI[G<I)'+;;<Y%31S'R1.EF:NJ+'&K%_#0),MNY6
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M*BT;<RR6+:N*5J*Q]]J:5'UU8B.^6FIIV1QKU173.5-'1H(9LU9E9
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M],:L"JG<B.]59YU;JCIGHG[C4Z)\JN[JM<(>3T^1X=L[T?33N@
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MS3931OED>KU<UN6W.=G;KU1K62M8B?)I]PK$K1 @
M   PA^76STMC\BG)*BI$1L4]7C]8]$8UB>UN&)6JX2=&]->^9=5]*^E>JD;A
M6Z%  %L_A+JZBF\@VVD,$JQQ5]GRB&L9HGKQML51.C5U3_AQM7I]P0EFW<K
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MY;!8%=HZ5R:M^<U/:JHZ5R+T3JC$71-55SG=U6L1#R.GT_AVSO1O-.[
M                          "2/%/BKN]S&WBQ_9G9RQ+<KW=%2:^WR5'M
MMMCM;'M;/7UTS47V<,7<GW7/<J,8CGN:U?7/-/FG2<GT=M1J)PK&Z.-IX1$=
ML_9OG8]F\I>4M9SK6UTVFKC:=\\*QQM,\(C[=T;9=AKPNX:[2<'=EK3L]M52
M/J7*]*W-\TJ6M2XY!>'Q-CEJZCM548FC$;%$U>V-B(B:KW.=^?WG+SCJ^=ZV
M=1G^BM8W5CLCWSQGV/T:\D>2M'R'0QI\B.^UIWVMVS[HX1[4M3U-[@
M        P_\ FM^T+W6_)F+?5VD)+=54(4  ?0XEE%YP?*\8S7'*AM)D.(7"
MBNEBJWQLE;%66^I95P/5DB*UR-?&BJUR*B^A0+/?UUOD+_O6MG]EL=_D@Q3P
MGZZWR%_WK6S^RV._R08GA/UUOD+_ +UK9_9;'?Y(,3PGZZWR%_WK6S^RV._R
M08GA/UUOD+_O6MG]EL=_D@Q/"?KK?(7_ 'K6S^RV._R08GA/UUOD+_O6MG]E
ML=_D@Q/"?KK?(7_>M;/[+8[_ "08GA>GN'F:\C%;,V6FWX@M+&M1JTU/B6&N
M8Y455[E6KM4SM5UTZ+IT]'I!@XSR3RC<_LJ;(VY\G;_2I*Y[G+;8[99E19'(
M]=%M%+3*B:IT1.B)T31%4&"*.>;T;P[I/63<W=?)-Q'JJ+W7R^7.[=475-/G
M\\OH^0*XS      !S'L+L/N5R3W2QC:':BPOON5Y-*C>[1S:6@I&N1)JRLE:
MUWLJ>%J]SWJGW$1%<K6J&\/A9Q V^X6[+6G:S#.VZWJI<VMW!SA\7LJF^7=\
M:,?,YJN>L<3$3LAB1RHQJ?*Y7.=6)E+@(    "'GD&^![E9[BY%^;I L.OD(
MV   &UGP9_ 5C_O/DGTF,K$KA0@          05\FGP$\HO=B?Z3"%A@+(V
M  &VKP@7%];P P>F?&C&V>_9-3QN15U>UUT?5ZKK\NLZI_D*Q*W0(
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MZL\NMHMRHL;ZR5J=OSFH;KU5>OLVK^"WY.Y5.YI3!Y+3Z?P[9WHN&W=
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MS-P]*>]               &'_P UOVA>ZWY,Q;ZNTA);JJA"@
M          $N.)'"G?3F9FS<6VHQY8[%;Y&)E^XE<V2&R6:)VBJLTS6N[Y5:
MNK((T5[O3HC=7(29;7>&'"#9[A+MTW#]O*1;SE=X;')GVYE9#&VZ7JJ8U/3V
MJ[V-,Q=?8T[7*UB+JJN>KGNK,RF2$      AYY!O@>Y6>XN1?FZ0+#KY"-@
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MP       AYY!O@>Y6>XN1?FZ0+#KY"-@  !M9\&?P%8_[SY)])C*Q*X4(
M        "LCS'_9O\C/T0^OEE"PPL$;   #>;XG?L].-'Y,NGUBN!6)6(A
M         IZ\YGP%9![SXW])D"PQ3$;   #?IXR_@)XN^[$'TF8K$IU!
M       JA\UWV>FZWY4Q;ZQ4@6&'\C8   ;]/&7\!/%WW8@^DS%8E.H(
M    =?)Y!?C@Y6>_>1?G&0C<(>!0 !>G^S[?&7N9_NQO/UJQP0EFPLK
M  ""ODT^ GE%[L3_ $F$+# 61L   -P'A1^STVI_*F4_6*K*Q*UX(
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M]T<ETF:NB3S-731B:?P3%ZI^$[JJ(WNJ4P>1TV1AMG>B2;=X
M                   '-''WC]NGR?W9Q39?9O&WY+F^6S*RFAU6.EHZ:-.Z
M>KJYM%2&G@9ZTCU^3HB*Y4:OAN?\_P!+RS26U&HMX:5]LSPB(XS/!YOR[Y=U
M?-=973::OBS+>R(XS,\(CC/O=@KX\_'[MAP!V?;A>+/;D^X^4I!4[K[FR1)'
M47>NB8J-BA:NJPT<'<Y((M>FJN<JO<Y5X"]0//VJY]J_S+_#EUV4KV1W]LSQ
MGU;H?HETYZ=Z7R]HORLOXLVVV]^-I[NRL<(]<[93^/0GT,
M  8?_-;]H7NM^3,6^KM(26ZJH0H                   ')6UFS>ZV]V2PX
M?M%M[=]Q<DF5G=;+313U;H6/=V)).^-JLAB1?3)(YK4]*JB :&N(?@0K9)[3
MFG,;*64]*Q63+LMC]4KY9.J.]E<;K"J-8G14?'2=RJBZMG:HP9FS2-M[MS@>
MT^)6C ]M,1H,'PZQ,5EJQVVTT=+31(J]SG=L:)W/<O5[W:N<NJJJJNI67V@
M      $//(-\#W*SW%R+\W2!8=?(1L   -K/@S^ K'_>?)/I,96)7"A
M      @KY-/@)Y1>[$_TF$+# 61L   -K/@S^ K'_>?)/I,96)7"A
M    ^+SS<C;W:RP3Y5N7G%HV_P :IETFOMYN-);:1'::HU):R2-JN7Y&HNJ_
M(@%3&]7G.X9;:2U5MP!]\WRO,&K6RV:A^86I)$U16OK+RM.Y4Z?A0PR-7Y%4
M+$*P-SOV@_D%?7U5/M-LSB^WE!-JV&KNTUQR*OC37HYKXGVV!'+_ ,:%R?\
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M3                  P_P#FM^T+W6_)F+?5VD)+=54(4
M^\QG:W<[-5C3#=N;]EJRHU8DMEHN%?W(Y'*FGS6*377L73]Q?N Q2IP3QI<\
M=Q70I8.+^44#9OP)+Y2Q8TS1'=NJKD<E#HGRI]U.J= F*?&UG@#Y3Y4ZEJ=T
M-P,6VGMLJM^<TL4M5D%UA:O5R^PHV04SE3Y$2KZK][J,$\2U/8_P3<0=MI*2
MY[G5U[WXO=.J.DIKC4K:+*KV]6N;1VAS)EZ]5;+4R-7T*FFNMP3Q+=]O]M-O
M-J,=I<1VRP>U8!C%&B>PL5HH*:WTR.1$;W*RF8Q'/73UG.U<J]555"/MP
M      "'GD&^![E9[BY%^;I L.OD(V   &UGP9_ 5C_O/DGTF,K$KA0@
M      05\FGP$\HO=B?Z3"%A@+(V   &UGP9_ 5C_O/DGTF,K$KA0@
M !QONON_MCL;A=SW#W<S:@P'#;2B?.[W<)O9L<]R+VQ1,:CI)I7Z>I%&USW?
M(B@9J^6_GORJ\3U^(\/\5;BEH:KXI-V,AI8JFYS:*K4DH;<YTD$+>FK75'M%
M5%ZQL4F+454 [F[N;H;SY+49ANQGUVW#R:HU1UWNU=/6RL8NG\'%[9RI'&FB
M(C&(C43HB(&G'8               "U[PI?:%[4_DS*?J[5B$LW %8
M 0\\@WP/<K/<7(OS=(%AU\A&P   VL^#/X"L?]Y\D^DQE8E<*$
M !61YC_LW^1GZ(?7RRA886"-@  !O-\3OV>G&C\F73ZQ7 K$K$0@
M  4]><SX"L@]Y\;^DR!88IB-@  !OT\9?P$\7?=B#Z3,5B4Z@@
M50^:[[/3=;\J8M]8J0+##^1L   -^GC+^ GB[[L0?29BL2G4$        .OD
M\@OQP<K/?O(OSC(1N$/ H  O3_9]OC+W,_W8WGZU8X(2S865@      !!7R:
M? 3RB]V)_I,(6& LC8   ;@/"C]GIM3^5,I^L565B5KP0          (*^33
MX">47NQ/])A"PP%D;   #<!X4?L]-J?RIE/UBJRL2M>"   !!WR5U512<#>4
MDM-*L,C\5K(G/3TK'/)'#(W]QS'JB_NA88 R-@  !LY\#5E2U\&ZRN1D;5R3
M-\@K7*Q7=SECH[?;M7ZHGK?ZKITUZ:?*5B5TH0            #"SYC_ +2#
MD9^B'U#LI&X5CA0 !9QX</M(..?Z7_4.]!);IBL              (5<L_'Q
MQ3YIVN2'>[;."JRN.'V-HW0M2MMF3T+6HJ,1E="Q5E8S5>V&H;+$BKKV:GN?
ME3S_ ,UY-;_QLR?!QK.VL^KAZ8PGO>C^;^G7*.>4PU67$WX7C9>/7Q]$XQW,
MS_)7]G$W^PRHK;SQBW)M>\^/=RNI<0O3H\=R&)JJO;&V:1SJ&H[41-9'20:J
MO1AR2\M_W$Z#.B*ZVDY5NVOQ5]GWH]&%O2XO^9_[:>8Y$S;0YD9M?IM\-O;]
MV?3C7T*5]X.%7+78*:I9N]QVRW"J.D5S9+_-9JN>T.5GX7L[C1LFI)-/2O9*
MO3KZ%0^R\H\Y\IU\?H9]+S/#Q1C_ ,LX3]CXASGR/SCE\S_49%Z1''PS-?\
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MI6?E[Y_%V1\OIW<&>N76W^O\7+M!;]#=>\?/^&OX>V?F_A^]58<B'%@
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M ",_1#Z^64+#"P1L   -YOB=^STXT?DRZ?6*X%8E8B$          "GKSF?
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M^+LCAQV[N$?6KKM_6Q;0<MM^ENOF1\_X:_A[9^;='P_>J>.1SBB
M       /\O>R-CI)'(QC$57O541$1$U555?D J>Y7<H/ZZ2U6W&W=Q<W$:=S
MH\DOL3M$NLC5T]E$Y.OS=JIU7_.+_P 5$[NYRZ8.^TN1\T^I LZCOP
M                         ^QV]V]S;=?-L9VXVXQFKS'.<QJXZ'&L:H8U
MEJ:NIE7HUJ=$1$1%<][E1K6HKG*C454[/F',,G2Y-L[.M%:5C&9G=$.]Y=R[
M/U>?7)R:S?,O.$1&^9_;V-[OBM\8.(\"=NWY)E[*/+.2F>4[/Z]YG&Q)(;12
MO1LGXHMLCT[D@8YJ+-*B(LST15]5L;6\$NJ/4S-Y[J/!EXUTU)^&O;/U6[^R
M.$=\R_0/I-TLR?+^F\>9A;57CXK=D?37N[9XSW1&%MI\H?8
M       ,/_FM^T+W6_)F+?5VD)+=54(4  <Z\7?B8X[>_6(_6"D!+L:2NF
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M_AC^:=O9AMAP-ZH]<-=S^9R,G')TOTX_%;^.8_VQL[<<(E!8^O/A@
M         _BJB(JJNB)Z5 JPY7<I69*EPVPVWK^['FJL6591"]?]?5JZ.IZ=
MS5_B->CWI_&>A/4U5_<Y>7AOWN[TV1XOBG<KX.H\D
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M"2W55"%  '.O%WXF..WOUB/U@I 2[&DKI@
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MQ&,S.R(B.,NKD9%\V\4I$VM:<(B-LS,[HB.UND\1_B<QWAKBMJWLWEME/?\
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ME8       05\FGP$\HO=B?Z3"%A@+(V   &X#PH_9Z;4_E3*?K%5E8E:\$
M        ""ODT^ GE%[L3_280L,!9&P   W >%'[/3:G\J93]8JLK$K7@@
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MS&,,_4WF)X1/ACV5PC[' JJJJJJNJKU55]*J>XO0W\"
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M.8_ECA''?/##G7T9Z05Y1EQJ]76)U5HV1O\ RXGA_%/&>&Z..-^)\(<@@
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M1L   -^GC+^ GB[[L0?29BL2G4$        .OD\@OQP<K/?O(OSC(1N$/ H
M O3_ &?;XR]S/]V-Y^M6."$LV%E8       05\FGP$\HO=B?Z3"%A@+(V
M&X#PH_9Z;4_E3*?K%5E8E:\$          ""ODT^ GE%[L3_ $F$+# 61L
M -P'A1^STVI_*F4_6*K*Q*UX(    #KJ.6^ OVNY1<A-OUA2"#%\QR&FMK$:
MC$6B_&DTE*Y&M1$1'0N8Y$3HFI'4A'@   O)\!FY[,3Y=Y9MU657LJ+=C$ZZ
M*WTNJ)[6Z66IAND7I_X-*VJ40EFQ4K             &%GS'_:0<C/T0^H=E
M(W"L<*  +./#A]I!QS_2_P"H=Z"2W3%8                %0'-W@E)=IKK
MO%LA9D=<9/:U.<8#3-1/G"HBR/JZ&-O^<715DA;^$O5J=VJ.Y-=)NK\9<5T6
MOM\.ZEYX=E;3V=D\-T[-W$+K;T*G-FW,.6U^+;-\N./;:D=O;6-^^-NR:6U1
M4545-%3HJ+Z44Y4N&#^!                         KVY8<HV6"*X;8;;
MW)5R)_=#E>2P/32@;U:^F@>W_/KZ'N1?X/T)Z^O9U\O+XR[C(R/'.,[E6*JJ
MKJO55]*G6>4 H                              \BDI*NX5=+04%+)6U
MU;(R&CHX6.DEFED<C&,8QB*KG.541$1-54S>\5C&=D0U2DVF(B,9EM2\-_B*
M3C91VGD[R4L44^_=YID?@& U,3)4PNDJ&:K/.CT5/QI*Q>U=/XABJS7O<[MX
M:=8.K/\ [*9T6CG]")^*T?//9'X8_P!4[=V&/-_HMT=_]96-=K:_^1,?#6?D
MB>,_CG_3&S?CAHA./CD>                        &'_S6_:%[K?DS%OJ
M[2$ENJJ$*  .=>+OQ,<=O?K$?K!2 EV-)73
M  AYY!O@>Y6>XN1?FZ0+#KY"-@  !M9\&?P%8_[SY)])C*Q*X4(
M $%?)I\!/*+W8G^DPA88"R-@  !M9\&?P%8_[SY)])C*Q*X4(    #![Y;,F
M?E7D*Y&UBRJ^&V5UIME,SUT;&VUX]04+FHC_ $:OB<Y=.BJJJGI(W"N,*  +
MF/!+9J*Y\[(*VK8KI\=P_(JRV.]7U9WOI+>JKJB_YNJ>G31>OW-45"6;1BL
M           PL^8_[2#D9^B'U#LI&X5CA0 !:]X4OM"]J?R9E/U=JQ"6;@"L
M       (>>0;X'N5GN+D7YND"PZ^0C8   ;6?!G\!6/^\^2?28RL2N%"
M        K(\Q_P!F_P C/T0^OEE"PPL$;   #>;XG?L].-'Y,NGUBN!6)6(A
M           IZ\YGP%9![SXW])D"PQ3$;   #?IXR_@)XN^[$'TF8K$IU!
M         JA\UWV>FZWY4Q;ZQ4@6&'\C8   ;]/&7\!/%WW8@^DS%8E.H(
M      =?)Y!?C@Y6>_>1?G&0C<(>!0 !>G^S[?&7N9_NQO/UJQP0EFPLK
M    ""ODT^ GE%[L3_280L,!9&P   W >%'[/3:G\J93]8JLK$K7@@
M    05\FGP$\HO=B?Z3"%A@+(V   &X#PH_9Z;4_E3*?K%5E8E:\$    !BE
M\XNV$F!<ZL@RF.G6*W[OV"QWZGD1/X-9Z>G7'YVIHFB.[K<CW)Z?71?E(W"G
ML*  )$<2MYW\>N2VRF\OM',H<$R"AJ+^C->]]IF?\SN,;=$7J^DFE:G1?2!V
M)]+54M=2TU;15,=915D;):2KB>V2*6*1J/8]CV*J.:Y%145%T5"NF_<
M       ,+/F/^T@Y&?HA]0[*1N%8X4  6<>'#[2#CG^E_P!0[T$ENF*P
M             %27.3@VF2)=]Y]F+1ID2=]3G&#TS.EP3J^2LHXV)_SCY9(T
M_C/PF^OJC^2?2/JY^1X=#KK?!NI>?E[*VGZ>R>&Z=F[B7UPZ'_U/BYCRZOZF
M^](^;MM6/J[8^;?'Q?>I)5%1514T5.BHOI13E@X3OX$
M     (&\JN4<>%PW#;?;VM27,*ACHLAOT3M4M3'MT6.)S?\ [RJ+U5/XO_E?
M@];+R^,NYR-/XML[E3;G.<Y7.57.<NKG+U554Z[R<1@_@4
M                ?UK7.<C6HKG.71K4ZJJJ!LE\-WA]BV=AQ7EGRAL#9]VZ
MED5?M'MA5-1S,6CD:DD5QKF+JBW%S51T42]*=/67^&T2'A]U@ZN3K)MH=%/Z
M6Z]H^;\,?A[9^;^'?S3Z+=&8T45YAKJ_K;Z4GY.RT_B[(^7^+[NE4XX.3H
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M!4345$]7/-554SZFIJ7NDJ*B1RODDD>JN<YSG*JJJJNJJIUWE(C!^04
M                          -=_AA\0%/BE+BW+_E5BKG9E,L5?LIM'<H$
M1MHCZ207BY02]5JW='4L#T_@4TD<GM5:D7$OK'U<G-FV@T-O@W7O''MK6>SM
MGCNC9CCS%Z)=&XR8KS'7U^/?ETGY>RUH[?ICAOG;AAJ,.,;E6
M               !A_\ -;]H7NM^3,6^KM(26ZJH0H  YUXN_$QQV]^L1^L%
M("78TE=,                          "'GD&^![E9[BY%^;I L.OD(V
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MLMUZLU?#=;/>((:JU72GD9-3U--41I+%+%)&JM>Q[7(YKD71475"L//
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M6661RO<][GJJN<Y5U55])W#RM:Q$80\<-
M    !JZ\+GB#D63&N87*W$$2)$@K]B-IKE$O<KM4FAO=RIY4Z(G1U'"].O\
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M>VM9[>V>&[?NY4]$^C4YTUYCKZ_!&VE)C[W9:T?3],<=\[,,=>IQ)<QP
M                        ##_YK?M"]UOR9BWU=I"2W55"%  '.O%WXF..
MWOUB/U@I 2[&DKI@                          0\\@WP/<K/<7(OS=(%
MAU\A&P   VL^#/X"L?\ >?)/I,96)7"A           @KY-/@)Y1>[$_TF$+
M# 61L   -K/@S^ K'_>?)/I,96)7"A     5>^7?C54\C.&^9/Q^WK<,[V>E
M;EN)01L5TT\=OADCN%.SM5%59*.25S6(B]SV,1$UTT+$L,9&P   ]C:+Q=L?
MNMMOUANE19+Y9IXJJSWFCGEIJNDJJ>1)8IH9H7-?'(QS4<US5145-44#3?P5
M\YUI=;K+MCS0;+27&E1E-;-]Z&E=-#4,:W1JWBCI45[9.FBU%.QR.U3NC;HY
MZF9AHMP7</ ]T,<HLOVXS*UYWBUQ36BR"TUU-<*23IJJ))2O>U')\K575%Z*
MFI67V(  !_'.:UJN<J-:U-7.7HB(@%>7)'RC\..-,-QH;_N=!G^;T2.1FWN*
MNBO-P]LB:^SGEA>E+3*G35)YFNT75&J%P9G.97F#Y'<HZ:ZX5A\G^PS:&X))
M%58K:*I\EUN=.]%8K+A<T;%(YCFJJ.AA;'&J+H]'Z(I&HA4D%      \RW7"
MLM-PH;K;IUI;A;)HJBAJ6HBNCFA>DC')W(J:HY$7J!V3.V&;T.YNVFWFY%L[
M?Q;N#8K3?+?VZJWV%VH(J^/37KIVRIH5TWW(      (>>0;X'N5GN+D7YND"
MPZ^0C8   ;6?!G\!6/\ O/DGTF,K$KA0@           *R/,?]F_R,_1#Z^6
M4+#"P1L   -YOB=^STXT?DRZ?6*X%8E8B$          "GKSF? 5D'O/C?TF
M0+#%,1L   -^GC+^ GB[[L0?29BL2G4$          "J'S7?9Z;K?E3%OK%2
M!88?R-@  !OT\9?P$\7?=B#Z3,5B4Z@@       !U\GD%^.#E9[]Y%^<9"-P
MAX%  %Z?[/M\9>YG^[&\_6K'!"6;"RL       (*^33X">47NQ/])A"PP%D;
M   #<!X4?L]-J?RIE/UBJRL2M>"          !!7R:? 3RB]V)_I,(6& LC8
M   ;@/"C]GIM3^5,I^L565B5KP0     ")'-_BQC_,+CIF^SMU]E27^HC2X[
M=9!(G_JS(:)CW4DRKHY4C?W.AFT358I'HG714+$NO]S'$,EV_P LR3!LRL\V
M/Y9B-;4V[(K)4-[)J6LI)702QN3[K7-7JG1?2G0C;YH    7C< ?,QG_ !SM
M]EVGY T=;NOLW;FQT]AO\+VR9)C],Q$8R*-U0]C*NFC1-&Q2.:]B=&O[41@9
MF&JG8WDCL;R3QAF6[([E6S/[4C6K704LRLKZ%STU1E915"1U%,]?D;+&U5]*
M:H5)AS>$   #UUWO%IL%LK;U?KI362SVV-9;C=JN>*FIJ>)OI?)+,YK&-3Y5
M540"D'F'YP]BMH*2[XCQOCAWWW+C[X8\D3VK,0M\J:IWNJ6.CDKE1=%1M,J1
MN3_/(J:+,6O"RE;V;Y[J\BMP+MN?O%F-5FF87?1KZZH5K8::G8JJRGI8(D;%
M! SN7MCC:C4557355533B4     +./#A]I!QS_2_ZAWH)+=,5@
M            K3YK<(*'=BCN&Y^U-MBMVY]&U\M[L<360PY Q-7N7IHUM6G[
MUZ_QGH=UT<GWGI3U9ORVT:35S,Z>=D3.V:?_ (]W#?'8XU]:NB.7S:EM;H:Q
M751MM6-D9G_Y]D_-NGA*@^KI*J@JJFAKJ:2BK:*1\591RL='+%+&Y6/8]CT1
M6N:J*BHJ:HIS'R\RMZQ:LXQ.V)C=,.!6;E7R[S6T3%HG"8G9,3'"7CFW3
M          BYR1Y'6K9BT?BBT>SNFX5WB5UJMKO6CHXG:M2IJ$3Y-47L9Z7*
MGW$53J9=,76R<F;SW*7+O=[G?[I<+W>:V2Y7:ZS23W"OE7NDEED<KG.5?OJI
MW+RM:Q$80]<&@                               TE^&SQ ,WP=CG+#E
M#8%_V.4TK:K:K:ZKC5%RN6%_JU]?&]$_ZM:YO\'$O_.535W\#TFXY]8.KG]%
MXM#HK?K;KVCY.Z/Q=L_+_%NY-=%>C7]?X=?KJ_H[Z4GY^^?P]D?-_#][9;''
M'%&R*)B111(C8XVHC6M:U-$1$3T(AP\F<7-6(P?[(H
M          !A_P#-;]H7NM^3,6^KM(26ZJH0H  YUXN_$QQV]^L1^L%("78T
ME=,                          "'GD&^![E9[BY%^;I L.OD(V   &UGP
M9_ 5C_O/DGTF,K$KA0@          05\FGP$\HO=B?Z3"%A@+(V   &UGP9_
M 5C_ +SY)])C*Q*X4(    #^.:US5:Y$<UR:.:O5%10,.?E>X/57$;?RMR'$
M+.Z#8S=Z>IN6W\\4:_-K55N=[6KM#E35&^P<[N@1?3"YJ)JK'Z1N)57!0
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ML       (*^33X">47NQ/])A"PP%D;   #<!X4?L]-J?RIE/UBJRL2M>"
M       !!7R:? 3RB]V)_I,(6& LC8   ;@/"C]GIM3^5,I^L565B5KP0
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M_P!G&T*X.        LX\.'VD''/]+_J'>@DMTQ6
M  !6WS3X04F\D59N7M=2P6S=*FC5UXM.K8:>_P <;.B*OX+*I$31CUT1_1KU
M3HY/NO2KJU;E<QI=7,VT\[IWS3_&O;'#?'9/&_K1T1ISF)UFBB*ZJ(VQNC,B
M/W7[)W3NGMB@RY6VXV:X5EJN]!-:[I;I'PU]NJ(WPSP2QKVN8]DB(YKD5-%1
M4.9.1GTS:1>DQ:L[8F-L3'=+@3J=-F9.9-,R)K:LX3$QA,3V3#PCJN@
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M(B)HB'#*]YM.,[9ESAI2*Q$1&$0\@RT
M ,/_ )K?M"]UOR9BWU=I"2W55"%  '.O%WXF..WOUB/U@I 2[&DKI@
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MUG<J1^S6HAD5$T3VC7N5&L54)+9N5@     "'GD&^![E9[BY%^;I L.OD(V
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MD')3CKCRU6S5TE=4Y_M_10JK\3J)5U?4TT4:+K;GN756M3^ 5=-/9:=D;B5
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MKE7O=+6U\\CI9I9'+JKGO>JJJK]U3K/(UK$1A#PPT
M            %]?A^\2MWY89)9^0>_EBEMO&+&ZES[/8ITE@GSBNIG*WV$/:
MK7-M\4C=*B9/XQ46*/K[1T?PKJYU7IRK+G2Z6<=3:-L_1$\9_%,;HX;YX1/(
M'HUT@OS?-C6:NN&EK.R/_P!DQPC\,3OGCNCC,;@K9;+;9+;;[-9K?!:+/:((
MJ6U6JEBCIZ:EIJ>-(HHHHHD:UC&-:C6M:B(B)HG0X3YN;:]IM:<9G;,SOF7.
MO*RJTK%:Q$5B,(B-T1V0\XPZ@                               8?\
MS6_:%[K?DS%OJ[2$ENJJ$*  .=>+OQ,<=O?K$?K!2 EV-)73
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M$      AYY!O@>Y6>XN1?FZ0+#KY"-@  !M9\&?P%8_[SY)])C*Q*X4(
M       "LCS'_9O\C/T0^OEE"PPL$;   #>;XG?L].-'Y,NGUBN!6)6(A
M        IZ\YGP%9![SXW])D"PQ3$;   #?IXR_@)XN^[$'TF8K$IU!
M      JA\UWV>FZWY4Q;ZQ4@6&'\C8   ;]/&7\!/%WW8@^DS%8E.H(
M   =?)Y!?C@Y6>_>1?G&0C<(>!0 !>G^S[?&7N9_NQO/UJQP0EFPLK
M ""ODT^ GE%[L3_280L,!9&P   W >%'[/3:G\J93]8JLK$K7@@
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M4]5C6M1$*QBQN^8_[2#D9^B'U#LI&X5CA0 !9QX</M(..?Z7_4.]!);IBL
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M8XC>[=C5DC?%')55E51/BBB:Z=[&(KG*B:N<B??!#&5^J>\A?^&BZ?SICO\
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M9[N8K-A><V>OR":Y8_/-2SR11UE[J:J%ROHY9HU[XWHY-'?+U*S*Q((
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M!'[ 86?,?]I!R,_1#ZAV4C<*QPH  LX\.'VD''/]+_J'>@DMTQ6
M                     !$3FEPMV=YR;.W':C=>W>PJX/:5.!9[31L==,=N
MCF=K:FF<[3N8[1&S0N7ME;T714:YOMODWSEK.2:R,_(G9NM6=UH[)]T[XGUP
M].\[^2-%S[13I]1&W?6T;ZSVQ[XW3'JF.OVYG<+MY>#F[U=M3NY:TDAJ$?4X
M/G5(R1;3D-M1_:E32R/1-'-U1LT+O7C=T75%:YW/?R=YRT?.])&?D3W6K.^L
M]D^Z=TOSP\[>2-;R'63I]1'?6T;K1VQ[XWQ/J1(/;'IX
M                  "Y'Q.^+#(N=>:.W#W'958QQCP2L9'DMWC22"JR:NCT
MD6UV^71.UJ)I\ZG:NL;51K?7<BM^/]5>J&7R/)_*R<+:F\;(X5CZI]T<>.R-
MOVGI%TGS.?Y_YV=C72TG;/&T_37^:>'#;.S>)A>%XGMUB>/8)@F/4F)X=B=)
M#0XWC=#"RGI*.DIV(R.**-B(B(B)_E]*]3@QK-9FZC-MFYMIM>TXS,[YES]T
M6BR=-DURLJL5I6,(B-D1$/ICMG=
M
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MNE32M;I)6T[&JV.55TZHYR.>R-S"XIDA
M
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M\'N+8^],4L.35[W>R]IVI):WVO7NU3LZUB)W??[?E$)9MJ*P
M                   $8>6O$39;FCM+<MHMZ; MPMDKEJ,;R2F5D5VL5R:Q
M6,K*&=S7=DB(NCFJBL>W5KVN:NA[-Y4\VZWDVKC/T\X3QB=UH[)C]IC?#U;S
M?Y.T/.]'.GU-<8WQ,;ZSVQ/;]D[I=?GSEX-;P<$-X*S;3<NC6YX]<UFJ-MMR
M:>%[+9D5L8]&^UB[E=[.>/N:VHIW.5T;E3JYCF/?SX\D>=]'SW1QG9,X6C9:
ML[ZS[XGA/'TXQ'YW^?/(>MY!K9R,^,:SMK:-UH]TQQCAWQ,3,+CW)Z0
M                           "V;Q8^,3,^>FY,>0Y73UF+<:,'JFIN%F\
M:>QEN=0QJ2I:+8^1%1U1(BHLTB(J01KW+ZSHVO\ E/5#J7D\BTW@IA;4WCX:
M]GXK=W9'&>[&8^O=)^EF?Y@U7CS,:Z6D_%;MGZ:]\\9^6._")WQ[>[>X3M1A
M.,[<;<8S28;@V&TD=#C6-4,:14U)31)T:U.JJJJJN>]RJYSE5SE5RJJ\$>8<
MPS]7GVSLZTVO:<9F=\S^WL?H+R[EV1I,BN3DUBF72,(B-T1^WM?9'9N]
M
M
M
M
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M&16*9=(PB(_;?VSOF=LOOCL'D
M
M
M
M                                          ?-4N98E795>,&HLFH*
MO,\?I*2OON*1U4#[A1T5>^6.GGFIVN61D<KH'HQRIHNBZ ?2@
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MK:C/MXLR\XS/NCLB-T1PA^B'(^1Z;ENDIIM/7PY=(PB/?/;,[YGC+E0\6\L
M
M
M
M
M               " 'D(YX83P>VEDODWS?(=W,N9-3[5X ]^OSFI:W1U95MC
M>U[:.G546145%>Y48U45W<TL0QF[7\T>06UG)*7E3;,VFO>ZUVK)JG,JRO59
M*6^TU4K?G%%60Q*QJTSVM:UK&=J1]K%C[%8Q4C6#<7Q%Y=;4<RMJ*#<W;*O]
MC50^SI\VPFHD8MRL-R5G<ZGJ&MT[FNT589D3MD;U314<UM9F$I@@
M  ?E//#30S5-3,VGIZ=KGSSO<C&,8Q.YSG.=HB(B)JJJ!AF\KO,^GY?<CZEF
M&W%:W9O:)E19=MYF.58;B]TJ.KKHU%^2JDC:V-?EACC541RJA&XA5^%  'M;
M%9+MDU[L^-V"@DNM]R"JIZ&RVN%O=-4U=7,V"&)B?*Y[WHU$^ZH'8M<:]F[=
MQ[V#VDV6MJQR1[=V*AM]?5Q-[8ZJX-B22MJ431/X^I?)*OWW%8ES>$
M                             <0;Z[#[5<E-L<DVAWFQ&FS/!\GB5E7;
MYVI[6GG1CFQU5+*GKP5,*N58Y6*CFKZ%TU0\OR/GNJY;J:ZC3VFMZ_;W3VQ/
M&)>&Y_R#2<STMM/J:Q?+MP[.^)X3'"88"/(WXVMU^ 6Y4M)<(*K,=C<HJ'_[
M,=VV4ZI!.UW=(V@N"Q)V05\;&KJSHDK45\?3N:SGGT[ZC:7GVFQC"N?6/BI[
MX[:S]FZ>&/YZ]2NF6K\O:K"<;Y%I^"^'V6[+1]N^..%;1]&?,@
M               3Y\>W +<WGYO)#@N+.DQG;O&_956ZNYSZ=\M+9Z![]$BC
MZ(V2LJ.UR4\*N371SET8QRIZ)Y_\^:;D.C_-O\69;92O&9]T1QGU;YA]!Z<]
M/=5YAUOY67\.77;>^&RL>^T\(]>Z)=@OQZX];4<7-J,8V9V9QB/&,*QB/2.-
M-'U==5O1/;5M;-HBS5,RIK)(OWD1$:C6IP$\P>8-5S356U&HMXKV]D1PB(X1
M'"/>_1/RYY<TG*M)73::OAI7VS/&9GC,\9]SFL\*\X
M
M
M
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MCHJO**MKV6Z-O>FBK3(U]4JM75CV1:_A($F6RTK
M                 XSWAV>VWW\VWRK:3=O%:;,\!S.F=37VQ5+5T<FJ.9+$
M]JH^*:)Z(^*5BH]CT1S51413R7*.;ZG0:FN?D6FN96<8F/VVQ/&-TP\7SGDV
MFYAIK:?45B^7>,)B?VV3&^)C;$[88'/)=XOMT. 6;I=Z9\V=<><OK)8]O-RV
MQJLM*]W=*RVW=(V-9#6-8BJUS?X.=J*]FBH^./G?TWZFZ7GV1X9^#45CXJ]O
MXJ]L?;&Z>$S^?75#I7JO+V?XH^/36GX;=GX;=EOLMOCC$59GT]\H
M               $U>"O!O=OG=O-;]M-NZ)]MQ>UO@J=T-R)HG.M^/6I\G:Z
M5Z]$DJ)4:YM-3HJ.D<B_@L:][/3//'G?2<BT<YV;.-IV5KQM/^$<9X>G")]X
M\@^0]9S_ %L9&3&%(VWMPK'OF>$<9[HF8["GC/QGVBXE;18YLOLOCC;#BEA;
MWU=6_MDK[K7R-:V>OKYVM:LU3,K4[G:(B(B,8C6-:U. 'F3S)J^;:NVHU%L;
MS[(CA$1PB/\ .=N,OT7\K^5]'R?1UTVFKX:5]LSQF9XS/^481$0Y]/ O80
M
M
M
M
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M75E4NK6KVZM;'$CDU;$QC5U5-2L2E,$
M         #X'=':[ -Z< RG:W=+%J7-,"S2E?1Y'CE8Q7PSPO5'(J*U4<R1C
MD1\<C%1['HCFJCD14[_E?--1HM17/R+37,K.,3'[>V-TQLEX_FO*M/KM/;(S
MZQ?+O&$Q/[;^R=\3MA@V\HWBNSK@3E[,OQ%]9G?&G+:CV6)YS*QKZNSU<B*Y
M+;=EA:UC9>B^QF1$9,U.B(]'-3G1TQZHY'/<G\O,PIJ:QMKPF/JKW=L;X]&U
MP ZK=)M1Y?SOS,O&^EM.RW&L_3;O[)W3Z<85%GUE\>
M   2ZX6\+=XN<F\5NVHVHMWL*2#V=3GN>U,;UM>.VM7]KJFI<W3N>[14AA1>
MZ5W1-$1SF^I><O.6CY)HYS\^=NZM8WVGLCWSNB/5#W'R1Y(UO/M;&GT\;-]K
M3NK';/NC?,^N8["KB7Q1VFX:[+XWLMM%:$I;7:6-FR+(Y61_C&_75\;6U%PK
MI&(G?+*K4T3\%C4:QB(QJ(G #S7YJU?.-9;49\XS.Z.%8X1'='VSMG:_1?RA
MY1T?)-#73:>,(C?/&T\;3WS]D;(V0DN>MO:
M
M
M
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MGSAWI8W2)-/X17F9E=F5D
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MN
M
M
M
M                       A?S2X,;,\W,!;C.X=(ZR9E9(YOZ@;GT4;'7.S
M3RZ.5-'*U)Z9[FI[6!ZHCDZM<Q_:]I8EBTY=\'=^N&&8+8-U,<6IQ>XRO;A^
MYE V2:QW>-JJJ)',J(L4Z(FKZ>5&R-]*(K%:Y8U$H>!0             'T6
M)8CE.>Y+9<-PG'JS*\LR.=E+8L=M]/+55E74/]#(HH4<YR]->B=$Z^@#7AXR
M?$E9^-C[-OGR%I*7)M^FHD^+XLU\=5;,2[V(J/[FHK)[@W5465JJR/\ S>JI
M[0,S*\PK(                                          !Z+)\8QS-
M<<OF(9?8Z7)L6R:EGH<AQZN@CJ:.MHZF-8I89HI4<U['M<J*BIHJ'7TVIS,G
M,C,RYFMJSC$QLF)CC#M]5I<K/RIR\R(M2T83$[8F)WQ,,-/E@\0^6<.+Y>=[
M-DK=597Q:N]0U\R=SZFOPNHJI>UM)6JJJ^2C5ZHVGJEUTU2.5>_M?+S<Z5]6
MLKG%(TVIF*ZJ(]$7PXQW]M?7&S&(X']7.CF=R7,G4Z6)MI)GTS29X3VU[+>J
M=N$S1N?;7P<                2!XP\9=U^7&\F*[)[/6)UVR7(I6NN%R>U
MZ4%GMK)&MJ+C7RL:[V5- CD5RZ*KE5&,1SW-:O@/,WF72\IT=M3J)PK7AQF>
M$1VS/^<[(F7L7E7ROK.<:VNFTU<;6WSPK'&TSPB/\HQF8AV%'!G@SL_P0V?I
M-M-M*1+ID5T2&HW*W*J(6,N>17-C%;[67M5WLX(^YS:>G:Y6QM5>KGN>]_ '
MSOYWU?/=7.=G3A6-E:QNK'OF>,\?1A$?HOY#\AZ+D&BC(R(QM.VUIWVGW1'"
M.'?,S,S2/3'NX
M
M
M
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M_<KPK'OF>,^Z(A^BO3SI]I/+^BC*RHQS+83>_&T^ZL<(X>F9E.\]&>_@
M
M
M
M
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M(G;)"V:-E-3O3T]\$$;NOI*F*P,(
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M?9P?HCTTZ<:;R[H_!7"V=;;>_;/9'X8X1ZYWK%#YZ^D
M
M
M
M
M                 'SU1B.*5<\M55XQ;ZJIG<KYZB2BIGR/<JZJKG.8JJJ_
M=4#V-NM-JM$3X+3;*>UPRN[Y(:>&.!KG:(FJI$C45=$]('L
M                                           ?A54M-6TU11UE.RKH
MZMCXJNDE8V2.6.1JL<Q[7HJ.:Y%T5%Z*AJMIK.,;)AFU8M&$[8ECF\O_ (:J
M[:BLR/E%Q)Q1]=M34K/7[I[1T$2OEQ9R-=/-7VZ)G5UM7172PM36G7JU/8](
M>7W2/K#75171:ZV&;NK>?F[(G\79/S>G?POZR]%;:2UM=R^N.3OO2/D[;5CZ
M>V/EX?#]W-(<D'&$         <B[2;3;@[Z;D8AM+M9C<V6Y]G-8RBQRQ0=K
M72RO17.<]\BM9''&QKGR2/5&L8BN<J(BJ>.YMS73Z'36S\^WARZ1C,_MQ[(X
MR\ER?E&IU^IKI\BOBS+SA$?MNB-\SPC:W^>,_P :FW?C^VUD5TE/F._F;TT2
M;I;EM8[L1J*DR6RVI*B.CHHGHBJJHCYGHDCT31C(^!?4GJ1J.?ZGC7(I/PU_
MFM^*?9$;(XS/Z%]+^F&F\NZ7A?47CX[?RU[*Q[9G;/"(LZ/FCZF
M
M
M
M
M
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M'2+HC&,X.]1.IFKY]G83\&16?AI[[=L_9'#C,\^.FG2S1^7LC&/CU%H^*_\
M+7LK]L[YX1%GA\S?4P
M
M
M
M
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MR>Y+R+1\NR(R=-2,ND<(C[9XS/?.URH>+>6
M
M
M
M
M
M                  0.Y _^T6J_]$I?_F*>]<@_^OZY?/\ S'_]GU0D'Q^_
M]G5-_P"EU7_SD/7^?_\ V/5#V/R[_P#6CTRYN/"O.@
M
M
M
M
E                                             !__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo_pharmingxoriginal.jpg
<TEXT>
begin 644 logo_pharmingxoriginal.jpg
MB5!.1PT*&@H    -24A$4@  !58   '0" 8   !*GS'$    "7!(67,  "XC
M   N(P%XI3]V   @ $E$051XG.W=36]D5WHG^"N-&K9GQI/A;B\:SC$RC=D.
MD#0PP"RF!\F:^0"D%[E.)GAC+=8G$/4)1*TCB"37N1"YF84-M\@>5;OLME1D
ME>URHV4KT]4L=W655&2I+'5!.<[!29U0A4)\B1MQ[OOO!P2R2DI%W)>(^_*_
MSWG.*R]>O,@      )C?J[85     $ Q@E4     @(($JP      !0E6 0
M   *$JP"     !0D6 4     *$BP"@    !0D& 5     * @P2H     0$&"
M50    " @@2K       %"58!      H2K (     %"18!0     H2+ *
M %"08!4     H"#!*@    ! 08)5     (""!*L       4)5@$     "A*L
M @     4)%@%     "A(L H     4)!@%0    "@(,$J     $!!@E4
M@(($JP      !0E6 0     *$JP"     !0D6 4     *$BP"@    !0D& 5
M     * @P2H     0$&"50    " @@2K       %"58!      H2K (
M%"18!0     H2+ *     %"08!4     H"#!*@    ! 08)5     (""!*L
M      4)5@$     "A*L @     4)%@%     "A(L H     4)!@%0    "@
M(,$J     $!!@E4     @(($JP      !0E6 0     *$JP"     !0D6 4
M    *$BP"@    !0D& 5     * @P2H     0$&"50    " @@2K       %
M"58!      H2K (     %"18!0     H2+ *     %"08!4     H"#!*@
M  ! 08)5     (""!*L       4)5@$     "A*L @     4)%@%     "A(
ML H     4)!@%0    "@(,$J     $!!@E4     @(($JP      !0E6 0
M   *$JP"     !0D6 4     *$BP"@    !0D& 5     * @P2H     0$&"
M50    " @@2K       %"58!      H2K (     %"18!0     H2+ *
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M@WNQ[^J@ <L"    T$F"52BHX:'JA' 5    H$2"52@@SK[?]%!U0K@*
M4!(]5F%.@\W11I9ECUNXO?1<!0   $A,Q2K,H<6A:C95N;K2@&4!    Z 05
MJW"#EH>JTRYBY>I)<Q8)    H)U4K,(U.A2J!K=4K@(   "D(5B%*W0L5)T0
MK@(    DH!4 7&*P.5K/LNR=#F\;;0$     EB!8A1FQFO,H5G=VF7 5
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MMG:ER@Q5CVJ<H&I186*K57U7 0  @!14K%(ZH6HMA*K?="M6KJXT;<$   "
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M^@_9#__R@^Q/_I\_SMY__R3[KQ]_,M]__$T[<?] $;=BR/J]89X?A9LO6P\
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M\@A5YQ;"U9/!YFBE)<M+!4;C\7GBJM55^PT  & Y@M4&$JK6XK2,H.'!X=E
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M?@]3AJ"->Y ]+8XT2#VYHX(WDA.L5LN/N)BR0]64047K_/"'_U&HVF[Z>/7
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M%:H" '2&-@#0<(+5ANA!N"I4+4D(58_?^V[VRN>?=W+]>D:HRJ(.8Z6JX?\
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M5N_]]T^$JMTA5 7:2D4* '1'J@>=V@% "02K'29<K58(53\Y^W&?5KG+A*I
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M       %O6J# 0     4(U@%     "A(L H     4)!@%0    "@(,$J
M $!!@E4     @(($JP      !0E6 0     *$JP"     !0D6 4     *$BP
M"@    !0D& 5     * @P2H     0$&"50    " @@2K       %"58!
M  H2K (     %"18!0     H2+ *     %"08!4     H"#!*@    ! 08)5
M     (""!*L       4)5@$     "A*L @     4)%@%     "A(L H
M4)!@%0    "@(,$J     $!!@E4     @(($JP      !0E6 0     *$JP"
M     !0D6 4     *$BP"@    !0D& 5     * @P2H     0$&"50    "
M@@2K       %"58!      H2K (     %"18!0     H2+ *     %"08!4
M    H"#!*@    ! 08)5     (""!*L       4)5@$     "A*L @     4
M)%@%     "A(L H     4)!@%0    "@(,$J     $!!@E4     @(($JP
M    !0E6 0     *$JP"     !0D6 4     *$BP"@    !0D& 5     * @
MP2H     0$&"50    " @@2K       %"58!      H2K (     %"18!0
M   H2+ *     %"08!4     H"#!*@    ! 08)5     (""!*L       4)
M5@$     "A*L @     4)%@%     "A(L H     4)!@%0    "@(,$J
M $!!@E4     @(($JP      !0E6 0     *$JP"     !0D6 4     *$BP
M"@    !0D& 5     * @P2H     0$&"50    " @@2K       %"58!
K  H2K (     %"18!0     H(LNR_Q_*&R%AGG2J-P    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
